Locate your nearest distributor

Location:
Type:
Text search:
Username:
Password:
Forgot password?

Literature



Specific literature, recommended reading concerning our products, or particular articles from various scientific journals are available on request - you may contact us by info(at)biohit.fi.

YearAuthorsTitleCategory
2016Goni E, Link A, Langner C, Venerito M, Malfertheiner P.Impact of preanalytical factors on stability of pepsinogen I, II and gastrin 17. Helicobacter 2016; 21(Suppl 1):99 (P01.17)Type: abstractGastroPanel
2016Kayamba VJ, Aaron S, Zyambo K, Morgan D, Heimburger D, Banda T, Kelly P.Use of Anti-Retroviral Therapy Has No Influence on the Occurrence of Gastric Premalignant Lesions in HIV Infected Zambian Adults. DDW 2016 poster presentation Tu1287Type: abstractGastroPanel
2016Krike P, Shums Z, Rudzite D, Isajevs S, Polaka I, Norman GL, Leja M.The prevalence of anti-parietal cell and anti-intrinsic factor antibodies, pepsinogens, gastrin-17 and H.pylori infection in corpus-restricted gastritis patients Helicobacter 2016; 21(suppl 1):161-162 (P09.02)Type: abstractGastroPanel
2016Lee YC, Chiang TH, Chou CK, Chiu HM, Wu MS. Serological Biomarkers for Gastric Cancer Screening in a Population That Has Undergone Mass Eradication of Helicobacter pylori. DDW 2016 poster presentation Su1035.Type: abstractGastroPanel
2016Lee YC, Chou CK, Chiang TH, Chiu HM, Wu MS.The Association Between Serum Pepsinogen Testing and Death From Gastric Cancer: A Sixteen-Year Population-Based Cohort Study. DDW 2016 poster presentation Su1034.Type: abstractPepsinogen
2016Marchesi F, Ricco M, Tartamella F, Forlini C, De Sario G, Rizzi N, Caleffi A, Di Mario F.Helicobacter pylori in severe obese patients undergoing roux-en-y gastric bypass: non-invasive follow-up and eradication therapy. Helicobacter 2016; 21(Suppl 1):138 (P07.03).Type: abstractGastroPanel
2016McFadden TM, Harte EC, Kelly LC, Richardson C, Hendolin P, Paloheimo L, McConnell I, Lamont JV, Fitzgerald SP.DEVELOPMENT OF A NEW BIOCHIP ARRAY FOR THE SIMULTANEOUS DETECTION OF PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17. AACC 2016. A011.Type: abstractGastropanel
2016Panozzo MP, Franceschi M, Baldassarre G, Morini A, Visonà A , Antico A.COMBINED USE OF SERUM MARKERS AND MORPHOLOGICAL EVALUATION IN EARLY CHRONIC ATROPHIC GASTRITIS DETECTION: PRELIMINARY RESULTS. National congress FISMAD 2016, Napels, ItalyType: abstractAtrophic gastritis
2017Selgrad M, Bornschein J, Varbanova M, Wex T, Malfertheiner P."SEROLOGICAL BIOPSY" FOR THE ASSESSMENT OF PRENEOPLASTIC CHANGES IN THE STOMACH OF PATIENTS UNDERGOING SCREENING COLONOSCOPY AND GASTROSCOPY. Gut 2011; Vol 60 (suppl 3): A162-163Type: abstractGastroPanel
2017SUN L, TU T, LIU J, GONG Y, XU Q, JING J, DONG N, YUAN YA comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population. Scand J Gastroenterol 2014; 49 (10): 1164-1172.Type: scientific articleGastrin 17
2016Skrebinska S, Santare D, Isajevs S, Liepniece-Karele I, Rudzite D, Kikuste I, Vanags A, Tolmanis I, Atstupens J, Murillo R, Park JY, Herrero R, Daugule I, Leja M.Helicobacter 2016;21(Suppl 1):97 (P01.12).Type: abstractHelicobacter
2016Wang X, Bin L, Hu Y, Zhang M, Chen C.Gastric Cancer Screening by Combined Serum Pepsinogen Levels and Gastritis Staging in China. DDW 2016 poster presentation Su 1050.Type: abstractPepsinogen
2016Urke A, Krike P, Shums Z, Rudzite D, Polaka I, Sivins A, Jelovskis I, Isajevs S, Bogdanova I, Boka V, Vikmanis U, Norman GL, Leja M.The prevalence of anti-parietal cell and intrinsic factor antibodies in patients with gastric adenocarcinoma.Helicobacter 2016; 21(suppl 1): 130-131 (P06.10)Type: abstractGastroPanel
2015Goni E, Riccò M, Franceschi M, Baldassarre G, Panozzo MP, Antico A, De Bastiani R, Scarpignato C, Di Mario F. GASTRIN 17 AS NON INVASIVE MARKER OF REFLUX DISEASE. UEGW 2015 Poster presentation P1740.Type: abstractGastroPanel
2010Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, Basso D, Plebani M, Graham DY.Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010; 31(10):1104-11. doi: 10.1111/j.1365-2036.2010.04277.Type: abstractGastroPanel
2009Reshetnikov OV, Kurilovich SA, Bobak M, Maliutina SK, Pylenkova EDGastrointestinal symptoms in adult population of Novosibirsk city: prevalence and risk factors. Ter Arkh. 2009;81(2):11-6. [Article in Russian].Type: scientific articleGastroPanel
2015Franceschi M, Massella A, Panozzo M, Baldassarre G, Sella D, Antico A, Cerofolini A, Goni E, Di Mario F. GastroPanel serum markers as a non-invasive method for the diagnosis of H. pylori-related Gastritis. Poster presentation P01.01 at European Helicobacter Study Group 2015 congress. Helicobacter 2015:20(Suppl. 1); 86.Type: abstractGastroPanel
2009Guariso G, Basso D, Bortoluzzi CF, Meneghel A, Schiavon S, Fogar P, Farina M, Navaglia F, Greco E, Mescoli C, Zambon CF, Plebani M. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. Clin Chim Acta 2009 Apr;402(1-2):54-60.Type: scientific articleGastroPanel
2014Masci E, Pellicano R, Mangiavillano B, Luigiano C, Stelitano L, Morace C, Viale E, Freschi M, Locatelli M, Ieri R, Cavallaro A, Testoni S, Testoni PA. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia. Minerva Gastroenterol Dietol. 2014 Mar;60(1):79-83.Type: scientific articleGastroPanel
2012Zhang Y, Sun L_P, Xing C-Z, Xu Q, He CY, Li P, Gong Y-H, Liu Y-P, Yuan YInteraction between GSTP1 Val Allele and H. pylori Infection, Smoking and Alcohol Consumption and Risk of Gastric Cancer among the Chinese Population. PLoS ONE 7(10): e47178.15.10.2012Type: scientific articleHelicobacter pylori igG
2012Salaspuro M. Interactions of alcohol and tobacco in gastrointestinal cancer. J Gastroenterol Hepatol 2012; 27 (Suppl 2): 135 -139.Type: scientific articleAcetaldehyde
2017F.Di Mario, A Franzè, L.G.CavallaroA non-invasive approach to diagnosis of upper gastrointestinal diseases. Area Qualitá S.r.l. 2008; 1-66Type: otherGastroPanel
2017Sipponen P, Salaspuro M, Härkönen MAtrofinen gastriitti. Biomerkkiainetutkimus ja atrofinen gastriitti - tärkeä mahalaukun syövän ja B12 vitamiinipuutoksen riskitila. Yksityislääkäri 2008; 3:99-106.Type: articleGastroPanel
2008Henriksson A"Vatsan limakalvon kunto selviää helposti verikokeella". Helikobakteeri kannattaa löytää ja häätää vatsasta ajoissa. Loviisan Sanomat 12.2.2008; vko 7, nro 12:11.Type: articleGastroPanel
2017Capelle L, de Vries AC, Haringsma J, Looman CW, Nagtzaam N, van Dekken H, Borg FT, de Vries R, Kuipers EJ.Serum Levels of Leptin As Marker for Patients At High Risk of Gastric Cancer. DDW 2009; W1887Type: abstractGastric disease
2012Di Mario F, Curlo M, Cavestro GM, Morana E, Savarino V, Rugge M, Cavallaro L G, Guida L, Franzè A."GastroPanel Test" in the clinical outcome of GERD. DDW 2009; S1921 Gastroenterol 2009; 136(5): A-293 (S1921)Type: abstractGastroPanel
2017Di Mario F, Gatta L, Franzè A, Rugge M, Scarpignato C, Dal Bò N, Morana EEffects of Helicobacter pylori eradication on serum pepsinogen I,II, ratio and gastrin -17 in Italia Italian and immigrant patients. Helicobacter 2009;14(4): 408 (P09.31).Type: abstractGastroPanel
2017Di Mario F, Guida L, Iori A, Cavallaro LG, Curlo M, Morana E, Venerito M, Malfertheiner P, Scarpignato C, Rugge M, Franzè APepsinogen II As Marker of Inflammation in H.P.Infection and NSAIDs Damage.Gastroenterology 2009; 136(5): A-613 (T1979).Type: abstractGastroPanel
2017Lee JH, Song HJ, Choi K-S, Kim DH, Choi KD, Lee GH, Jung H-Y, Kim J-H.Performance and Clinical Implications of Serum Pepsinogen I in Patients Undergoing Endoscopic Mucosectomy Due to Early Gastric Tumors. Gastroenterol 2009; 136(5): A-732 (W1820).Type: abstractPepsinogen I
2017McNicholl AG, Gispert JP.Accuracy of GastroPanel for Non Invasive Diagnosis of Atrophic Gastritis. DDW 2009; M1055 Gastroenterol 2009; 136(5): A-340 (M1055).Type: abstractGastroPanel
2017Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA.Pepsinogen I levels and Helicobacter pylori in Siberian populations. Helicobacter 2009; 14(4): 337 (P01.01).Type: abstractGastroPanel
2011Attumi TA, Graham DY. Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations. Clin Gastroenterol Hepatol 2011; 9:373-375.Type: scientific articleHelicobacter pylori infection
2014Di Mario F, Goni EGastric acid secretion: Changes during a century. Best Pract Res Clin Gastroenterol. 2014; 28(6):953-965.Type: scientific articleGastric disease
2013Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H.Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev 2013; 5:821-826. DOI: 10.1158/1055-9965.EPI-12-1343Type: scientific articleGastroPanel
2009Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis?Scand J Gastroenterol. 2010;45(2):133-138Type: scientific articleGastroPanel
2009Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner HAlcohol consumption and chronic atrophic gastritis: Population-based study among 9,444 older adults from Germany Int J Cancer 2009; 125:2918–2922.Type: scientific articleGastric disease
2009Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa TSerum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.World J Gastroenterol 2009;15(7):853-859Type: scientific articleGastroPanel
2009Ren JS, Kamangar F, Qiao YL, Taylor P, Liang H, Dawsey S, Liu B, Fan JH, Abnet C.Serum pepsinogens and risk of gastric and esophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 2009; 58:636-642Type: scientific articlePepsinogen
2008Sun LP, Gong YH, Wang L, Gong W, Yuan YFollow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay J Dig Dis. 2008 Feb;9(1):20-6Type: scientific articleGastroPanel
2008Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Bessonov PP, Vasil'ev RR, Tatarinova OV, Muchina EGPrevalence of atrophic gastritis in different populations in Siberia on medical evidence of the serological survey. Klin Med (Mosk). 2008;86(7):35-8.Type: scientific articleGastroPanel
2007Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EVHelicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogenII levels in patients with duodenal ulcer. J Gastroenterol Hepatol 2008; 23: 1666-1671.Type: scientific articleGastroPanel
2007Sun LP, Gong YH, Wang L, Yuan YSerum pepsinogen levels and their influencing factors: A population-based study in 6990 Chinese from North China. World J Gastroenterol 2007 December 28; 13(48): 6562-6567Type: scientific articleGastroPanel
2017Madrigal B, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras C, Esteban C, Santolaria S, Gomollon F, Valle J and Gisbert JP. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2014; 26:941–948.Type: abstractGastroPanel
2011Salaspuro M. Acetaldehyde and gastric cancer. J Dig Dis 2011; 12: 51–59.Type: scientific articleAcetaldehyde
2009Salaspuro M. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scan J Gastroenterol 2009; 44:912-925.Type: scientific articleAcetaldehyde
2013 Ahn JS, Eom CS, Jeon CY, Park SMAcid suppressive drugs and gastric cancer: A meta-analysis of observational studies. World J Gastroenterol 2013;19(16): 2560-2568.Type: scientific articleGastric disease PPI
2017Tsukanov V, Vasyutin A, Amelchugova O, Tretyakova O, Saaya A, Rodina D. ETHNIC FEATURES OF ATROPHIC GASTRITIS PREVALENCE AND GASTRIC CANCER INCIDENCE IN THE POPULATION OF EASTERN SIBERIA. UEG J 2013; A268-269 (P506).Type: abstractGastroPanel
2007Koivusalo AI, Pakarinen MP, Kolho KLIs GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children? Diagn Microbiol Infect Dis. 2007 Jan;57(1):35-8. Epub 2006 Sep 1Type: scientific articleGastroPanel
2006Halliday JCysteine gum may reduce tobacco, alcohol cancer risk. Published online www.nutraingredients.com, 29 May 2006 20.9.2006Type: scientific articleAcetaldehyde
2006Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko METime course changes inmorphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers. Ter Arkh. 2006; 78(2):26-31. [Article in Russian].Type: scientific articleGastroPanel
2004Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes World J Gastroenterol 2004;10(21):3146-3150Type: scientific articleGastroPanel
2017Benberin VV, Bektaeva RRPrecancerous diseases of the digestive system – modern possibilities of prevention of gastric cancer. Herald MC UDP RK Ser Medicine 2012; 4(47):2-6. (Ru).Type: scientific articleGastric disease
2017Paloheimo L, Tiusanen T, Härkonen M, Sipponen P. Mahalaukun limakalvon terveystesti. Tulokset GastroView- merkkiainetutkimuksesta Valtakunnallisilla Lääkäripäivillä Helsingissä 2007.Yksityislääkäri 2007; 3:89-90Type: articleGastroPanel
2009de Vries AC, van Driel HF, Richardus JH, Ouwendijk M, van Vuuren AJ, de Man RA, Kuipers EJMigrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. Scand J Gastroenterol. 2008;43(4):403-9.Type: scientific articlePepsinogens
2008Pimanov SI, Makarenko EVPotentialities of a serological method in diagnosis of atrophic gastritis. Ter Arkh 2008: 80(2); 15-21. [Article in Russian]Type: scientific articleGastroPanel
2009Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M and Agréus LSerum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008; 43:1448-1455.Type: scientific articleGastroPanel
2007Parthasarathy G, Maroju NK, Kate V, Ananthakrishnan N, Sridhar MG. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach. Trop Gastroenterol 2007; 28(4):166-70.Type: scientific articleGastroPanel
2013Furnari M, Bonfanti D, Parodi A, Franzè J, Savarino E, Bruzzone L, Moscatelli A, Di Mario F, Dulbecco P, Savarino V.A comparison between lactose breath test and quick test on duodenal biopsies for diagnosing lactase deficiency in patients with self-reported lactose intolerance. J Clin Gastroenterol 2013;47:148–152. doi: 10.1097/MCG.0b013e31824e9132Type: scientific articleLactose Intolerance
2006Salaspuro V, Hietala J, Marvola M, Salaspuro MEliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epidemiol Biomarkers Prev 2006;15:146-149.Type: scientific articleAcetaldehyde
2017Lachenmeier DW, Salaspuro M.ALDH2-deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde. Regulatory Toxicology and Pharmacology 2017. Regulatory Toxicology and Pharmacology 86 (2017) 128e136.Type: scientific articleAcetaldehyde
2006Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L, Chavez A, Cardenas VNoninvasive Versus Histologic Detection of Gastric Atrophy an Hispanic Population in North America. Clin Gastroenterol Hepatol 2006; 4:306-314.Type: scientific articleGastroPanel
2006Kuokkanen M, Myllyniemi M, Vauhkonen M, Kääriäinen I, Karesvuori S, Linnala A, Härkönen M, Järvelä I, Sipponen PA biops-based guick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy 2006;38(7):708-712. Type: scientific articleLactose Intolerance
2009Goetze JP, Paloheimo LI, Linnala A, Sipponen P, Palnœs Hansen C, Rehfeld JFShort report. Gastrin-17 specific antibodies are too specific for gastrinoma diagnosis but stain G-cells. Scand J Gastroenterol 2005; 40:596-598.Type: scientific articleGastric disease
2005Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, De Rosa G, Budillon. GDiagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther 2005; 22:1139–1146.Type: scientific articleGastroPanel
2013Ebule IA, Longdoh AN, Paloheimo LIHelicobacter pylori infection and atrophic gastritis. African Health Sciences 2013; 13(1): 12 – 117.Type: scientific articleGastroPanel
2010Redéen S, Ryberg A, Petersson F, Eriksson O, Nägga K, Borch KHomocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia. Dig Dis Sci 2010; 55(2):351-8.Type: scientific articleGastroPanel
2004Di Mario F, Moussa AM, Cavallaro LG, Caruana P, Merli R, Bertolini S, Iori V, Cavestro GM, Dal Bò N, Pilotto A, Franzé A, Leandro GClinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Digestion 2004; 70:167-172.Type: scientific articlePepsinogen II
2004Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Boldys H, Romanczyk TNon-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastro-Enterologica Belgica 2004; Vol. LXVII:320-326.Type: scientific articleGastroPanel
2003Broutet N, Plebani M, Sakarovitch C, Sipponen P, Mégraud FEurohepygast Study Group. Pepsinogen A, Pepsinogen C, and Gastrin as Makers of Atrophic Chronic Gastritis in European Dyspeptics. British Journal of Cancer 2003; 88: 1239-1247.Type: scientific articleGastroPanel
2003Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Dal Bó N, Iori V, Pilotto A, Leandro G, Franze A, Rugge M"Serological Biopsy" in First Degree Relatives of Patients with Gastric Cancer Affected by Helicobacter pylori Infection. Scand J Gastroenterol 2003;28:1223-1227. Type: scientific articleGastroPanel
2003Gøtze JP, Rehfeldt JFImpact of Assay Epitope Specificity in Gastrinoma Diagnosis. Clin Chem 2003; 49 No 2: 333-4.Type: scientific articleGastric disease
2003Konturek SJ, Konturek PC, Bielanski W, Karczewska E, Zuchowicz M, Hartwich A, Rehfeld JF, Goetze JP, Hahn EGSerum Progastrin and Its Products, Gastric Acid Secretion and Serum Pepsinogen I in Gastric Cancer. Digestion 2003; 68:169-177.Type: scientific articleGastric disease
2003Kuipers EJIn through the Out Door: Serology for Atrophic Gastritis, European Journal of Gastroenterology & Hepatology 2003; 15: 877-879.Type: scientific articleGastroPanel
2003Sipponen P, Härkönen M, Alanko A, Suovaniemi ODiagnosis of Atrophic Gastritis from a Serum Sample. Minerva Gastroenterol Dietol 2003; 49: 11-21.Type: scientific articleGastroPanel
2003Sipponen P, Laxen F, Huotari K, Härkönen M.Prevalence of Low Vitamin B-12 and High Homocysteine in Serum in an Elderly Male Population. Associociation with Atrophic Gastritis and H.pylori Infection. Scand J Gastroenterol 2003; Vol 38 (12): 1209-1216.Type: scientific articleGastric disease
2003Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M, Jussila A, Sipponen P.Non-Endoscopic Diagnosis of Atrophic Gastritis with a Blood Test. Correlation between Gastric Histology and Serum Levels of Gastrin-17 and Pepsinogen I. A Multicenter Study. Eur J Gastroenterol Hepatol 2003; 15: 885-891.Type: scientific articleGastroPanel
2002Sipponen PGastric Cancer. Pathogenesis, Risks, and Prevention. J Gastroenterol 2002; 37 (Suppl XIII): 39-44.Type: scientific articleGastric disease
2002Sipponen P, Härkönen M, Alanko A, Suovaniemi O Diagnosis of Atrophic Gastritis from a Serum Sample. Clin Lab 2002; 48:505-515.Type: scientific articleGastroPanel
2002Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.Serum levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control Study. Scand J Gastroenterol 2002; 37: 785-791.Type: scientific articleGastric disease
2001Sande N, Nikulin M, Nilsson I, Wadström T, Laxen F, Härkönen M, Suovaniemi O, Sipponen PIncreased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001; 36:928-933.Type: scientific articleGastroPanel
2001Sipponen P.Clinical Reviews. New Techniques. Update on the Pathologic Approach to the Diagnosis of Gastritis, Gastric Atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001; 32(3):196-202.Type: scientific articleGastroPanel
2017Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Pylenkova EDSymptoms of gastroesophageal reflux in the population: association with serum biomarkers. Helicobacter 2009;14(4): 366 (P05.17)Type: abstractGastroPanel
2017Venerito M , Kohrs S , Wex T, Mönkemüller K, Schubert D, Adolf D, Malfertheiner P. Helicobacter Pylori Infection, Gastric Atrophy and the Risk for Oesophageal Squamous Cell Carcinoma in Germany DDW 2009: W1895Type: abstractGastroPanel
2006Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L. Meurman JH, Salaspuro MAcetaldehyde production from ethanol by oral Viridans Streptococci. Presentation at the 11th International Congress on Oral Cancer (ICOOC) May 14-17 2006 in Grado, Italy.Type: abstractAcetaldehyde
2017Curlo M, Iori A, Guida L, Cavallaro L, Dal Bò N, Rugge M, Franzè A, Di Mario FClinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Helicobacter 2008; 13(5):449.Type: abstractPepsinogen II
2017Panozzo MP, Franceschi M, Baldassarre G, Morini A, Visonà A , Antico A. COMBINED USE OF SERUM MARKERS AND MORPHOLOGICAL EVALUATION IN EARLY CHRONIC ATROPHIC GASTRITIS DETECTION: PRELIMINARY RESULTS. National congress FISMAD 2016, Napels, Italy.Type: abstractGastroPanel
2012Demiray E, Yýlmaz Ö, Soytürk M, Bekmen N, Gönen C, Güvenir M, Saðol Ö, Dölek D, Þimþek IA perspective for the detection of Helicobacter pylori infection by four noninvasive tests. Helicobacter 2008; 13(5): 450-451.Type: abstractGastroPanel
2011Linderborg K, Salaspuro M, Väkeväinen S. A single sip of a strong alcoholic beverage causes exposure to carcinogenic concentrations of acetaldehyde in the oral cavity. Food Chem Toxicol. 2011; 49(9):2103-6.Type: scientific articleAcetaldehyde
2017Iori A, Curlo M, Guida L, Cavallaro L, Merli R, Minelli R, Maini A, Bertelè A, Franzè A, Di Mario FIs H. pylori infection related to body atrophic gastritis in patients affected by Autoimmune Thyroid Diseaes (AITD )? Helicobacter 2008; 13(5):438.Type: abstractGastroPanel
2017Leja M, Chiu HM, Funka K, Jonaitis L, Kiudelis G, Kupcinskas L, Sudraba A, Tolmanis I, Lin JTThe value of pepsinogen II in the detection of active H.pylori infection. Helicobacter 2008; 13(5):407.Type: abstractPepsinogen II
2017McNicholl AG, Forné M, Barrio J, De la Coba C, González B, Rivera R, Fernandez-Bañares F, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras-Alastruey C, Esteve-Comas M, Esteban C, Gisbert JPAccuracy of GastroPanel for non invasive diagnosis of atrophic gastritis. Helicobacter 2008; 13(5): 453.Type: abstractGastroPanel
2017McNicholl AG, Forné M, Barrio J, De la Coba C, González B, Rivera R, Fernandez-Bañares F, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras-Alastruey C, Esteve-Comas M, Esteban C, Gisbert JP. Accuracy of GastroPanel for non invasive diagnosis of atrophic gastritis. Helicobacter 2008; 13(5): 453 (P108).Type: abstractGastroPanel
2017Myllyniemi M, Hendolin P, Telaranta-Keerie A, Nikulin M, Paloheimo LI, Engstrand L, Sipponen PNew specific Helicobacter pylori IgG ELISA test. Helicobacter 2008; 13(5):472.Type: abstractGastric disease
2017Vauhkonen M, Helske T, Kääriäinen I, Hyvärinen H, Karesvuori S, Paloheimo LI, Sipponen P.Quick test for detection of Helicobacter pylori urease activity in gastric biopsy specimen. Helicobacter 2008; 13(5): 473.Type: abstractHelicobacter
2017Di Mario F, Farkas HP, Ferrara F, Dal Bo N, Slongo T, Marcello R, Rugge M, Scarpignato C.Recovery of Gastric Function After Acetium Administration: a 6 Months Study in Atrophic Gastritis Subjects. Gastroenterology 2014; 146 (5): S-506 (Su 1951). DDW 2014 poster abstract Su1951 (A-855).Type: abstractGastroPanel Acetium
2017Weck MN, Brenner HAssociation of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition. Helicobacter 2008:13(5);404.Type: abstractGastroPanel
2017Härkönen M, Nikulin M, Sande N, Suovaniemi O, Sipponen P. Atrophic corpus gastritis raises the serum levels of homocysteine. Presented at the Digestive Disease Week, USA, May 20-23, 2001Type: abstractGastroPanel
2017Weck MN, Gao L, Brenner HHelicobacter pylori infection and chronic atrophic gastritis: 3-, 10- or 20-fold increased risk? Helicobacter 2008; 13(5):413-414.Type: abstractGastroPanel
2017Yýlmaz Ö, Demiray E, Soytürk M, Perez Perez GI, Saðol Ö, Bekmen N, Þimþek I, Akpýnar HThe effect of H. pylori eradication on serum pepsinogen I and II levels, gastrin-17 and Helicobacter pylori antibodies in patients with dyspepsia. Helicobacter 2008;13(5): 453-454 (P110)Type: abstractGastroPanel
2017Makarenka AV, Pimanov SI. The Improvement of antral Histology, Serum Gastrin-17, Pepsinogen-I and Pepsinogen-II Levels after Eradication is Related to Residual Bacterial Load in Patients with Duodenal Ulcer. Gut 2005; 54 (Suppl VII):A9Type: abstractGastroPanel
2017Bautista-Marguez A, Guerrero-Almeida ML, Luqueno-Matrinez V, Mucino-Bermejo J, Ruiz-Palacios GMLevels of Serum Pepsinogen Correlate with the Immune Response of Helicobacter pylori in a Cohort of Mexican Children. Helicobacter 2006;11(4): 354 (05.25).Type: abstractPepsinogen
2017Cavallaro LG, Maini A. Nouvenne A, Morana E, Merli R, Venerito M, Iori V, Cavestro GM, Rugge M, Malfertheiner P, Franze A, Di Mario FSerum Pepsinogen II as a Marker of Both Helicobacter pylori and Acetyl Salicylic Acid-Related Gastritis. Helicobacter 2006;11(4): 395 (12.02).Type: abstractPepsinogen II
2006Cavallaro LG, Nouvenne A, Maini A, Merli R, Fanigliulo L, Basso D, Plebani M, Iori V, Cavestro GM, Maino M, Nervi G, Franze A, Di Mario FGastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of Gastro-Esophageal Reflux Disease (GERD) independently of H.pylori status. Gastroenterol 2006; Vol 130 (4) (Suppl 2):A-168 (S1168).Type: abstractGastrin 17
2017Figura N, De Apollonia L, De Marco L, Santucci A, Canzonieri, Serraino D, Nuti R, Campagna S, Gonnelli C, Lezi C, Sozzi MIncreased Amidated Gastrin-17 (PGL) Systemic Levels and Gastric Epithelial Cell Proliferation (GECP) in Dyspeptic Patients with CagA-Positive (CagA+) Helicobacter pylori Infection. Helicobacter 2006;11(4): 335 (03.17). Type: abstractGastrin 17
2017Di Mario F, Ferrara F, Dal Bò N, Slongo T, Heras Salvat H, Schiavinato A, Marcello R, Caroli A, Loperfido S, Scarpignato C. Is H. pylori Eradication Useful in the Improvement of Dyspepsia?: a 15 Years Study. Gastroenterology 2013;144 (5): S-680-681 (Mo1875). DDW 2013 poster abstract; Mo1875 (A-1112).Type: abstractGastroPanel
2017Moenkemueller K, Peitz U, Wex T, Jaspersen D, Labenz J, Meyer-Sabellek W, Willich SN, Stolte M, Lind T, Malfertheiner P.Pepsinogen I correlates with severe esophagistis and Barrett’s esophagus.Gastroenterol 2006; Vol 130 (4) (Suppl 2):A-390 (M1994).Type: abstractGastroPanel
2017Nouvenne A, Cavallaro LG, Maini A, Bertele A, Cavestro GM, Franze A, Di Mario F. Gastrin-17The Key in Order to Understand Relationship between Helicobacter pylori and Gastroesophageal Reflux Disease. Helicobacter 2006;11(4): 356 (06.07).Type: abstractGastroPanel
2017Ruiz Palacios y Santos GM, Luqueno V, Bautista Marguez A, Mucino Bermenjo J.Relation between the Pattern of Serum Pepsinogen Changes and the Magnitude of the Immune Response to Helicobacter pylori Infection in a Cohort of Young Mexican Children. Helicobacter 2006;11(4): 353 (05.22).Type: abstractGastroPanel
2017Sipponen P.Diagnosis of Atrophic Gastritis with Plasma Biomarkers. Presentation at the 6th Western Pacific Helicobacter Congress 12.-14.11.2006, Bangkok, Thailand. Helicobacter 2006; 11(2): 2-3.Type: abstractGastroPanel
2017Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin HGastric Corpus Athophy and Without Evidence of Helicobacter pylori Infection. Helicobacter 2006;11(4): 357 (06.08).Type: abstractGastroPanel
2005Cavallaro LG, Mahamat Moussa A, Maini A, Liatopoulou S, Bertolini S, Merli R, Caruana P, Iori V, Maino M, Cavestro G, Nervi G, Colla G, Rugge M, Franze' A, Di Mario FAccuracy of “Serological Gastric Biopsy” in a Cohort of Dyspeptic Patients. Gut 2005; 54 (Suppl VII) :A99.Type: abstractGastroPanel
2017Cavallaro LG, Merli R, Liatopoulou S, Franzè I, Maino M, Iori V, Cavestro G, Gnocchi A, Caruana P, Franzè A, Di Mario F.Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients. Helicobacter 2005; 10 (5):503.Type: abstractGastroPanel
2017Sipponen P, Härkönen M, Suovaniemi O, Wickström M.GastroPanel- ja GastroView- tutkimukset: Uusi mahdollisuus dyspepsia-tyyppisistä vaivoista kärsivien tutkimus- ja hoitokäytännön kehittämiseen,.Yksityislääkäri 2007; 3:89-90.Type: articleGastroPanel
2017Härkönen M.Onko maha terve vai ei? Uusi yksinkertainen verikoe antaa vastauksen. Olé 2007; 4:72-75Type: articleGastroPanel
2017Kuokkanen M, Myllyniemi M, Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Karesvuori S, Linnala A, Harkonen M, Jarvela I. A quick test for perendoscopic diagnosis of hypolactasia from postbulbar duodenal biopsy. Gut 2004; 53(Suppl VI): A284 (WED-G-266). Type: abstractLactose Intolerance
2004Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, Wang X, Wang BL, Miao JY, Ding J, Fan DM.Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Dig Dis 2004;5(1):22-27Type: scientific articleGastroPanel
2017Di Mario F, Slongo T, Dal Bò N, Ferrara F, Murer F, Guarnieri G, Marcello R, Loperfido S, Heras Salvat H, Savarino V, Scarpignato C.A NEW APPROACH TO DETECTION OF NON-RESPONDER PATIENTS IN GERD BY NON-INVASIVE MARKERS. Gut 2012; 61 (Suppl 3): A197 (P0441).Type: abstractGastroPanel
2003Salaspuro MP. Alcohol consumption and cancer of the gastrointestinal tract. Best practice & Research Clinical Gastroenterology 2003; 17(4):679-674.Type: scientific articleacetaldehyde
2007Valle Muňos J, Varasa TA, Pardo RL, Merlo RR, Grueso MJP, Escobedo RM, Torres MA, Boy RC, Jimenez JMC.Diagnóstico serológico de gastritis atrófica con una combibación de pepsinógeno I y II, gastrina-17 y anticuerpos anti-Helicobacter pylori. Gastroenterol Hepatol 2007; 30(10):567-571.Type: scientific articleGastroPanel
2007Weck MN, Stegmaier C, Rothenbacher D, Brenner HEpidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 2007; 26:879–887Type: scientific articlePepsinogens
2009Sipponen P, Graham DYImportance of atrophic gastritis in diagnostics and prevention of gastric cancer: Application of plasma biomarkers. Scand J Gastroenterol 2007; 42:2-10.Type: scientific articleGastroPanel
2006van Oijen MGH, Vlemmix F, Laheij RJF, Paloheimo L, Jansen JBMJ, Verheugt FWA. Hyperhomocysteinaemia and Vitamin B12 Deficiency: The Long-Term Effects in Cardiovascular Disease. Cardiology 2007;107: 57-62.Type: scientific articleGastroPanel
2010 Telaranta-Keerie A, Kara R, Paloheimo L, Härkönen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4256 volunteers without specific complaints. Scand J Gastroenterol 2010; 45:1036-1041.Type: scientific articleGastroPanel
2009Jolanda F, Parodi A, Savarino E, Morana E, Bertelè A, Savarino V, Di Mario FComparison Between Lactose Breath Test and a Quick Test On Duodenal Biopsies for Lactase Deficiency, in Patients with a Self Reported Lactose Intolerance. Gastroenterology 2009; 136(5): A-323 (S2067).Type: abstractLactose Intolerance
2012Rao P, Rao N, Jordinson M, Scott C, Hinchcliffe C, Campbell D. Comparison of quick point of care test for small bowel hypolactasia with biochemical lactase assay in children. J Pediatr Gastroenterol Nutr. 2012; 54 (3):401-403.Type: scientific articleLactose Intolerance
2017Moussa AM, Di Mario F, Cavallaro LG, Merli R, Bertolini S, Dalbò N, Aragona G, Iori V, Pilotto A, Leandro G, Cavestro GM, Franzé A. Clinical Usefulness of Serum Pepsinogen II in the Assessment of H. pylori Infection. Helicobacter 2003; Vol 8(4): 479 (A17.02)Type: abstractPepsinogen II
2017Syrjänen, K. Role of Serological Biomarker Testing (GastroPanel®) in Diagnosis of Symptomatic Dyspepsia and in Screening of the Risks of Stomach Cancer. EC Gastroenterology and Digestive System 2017; 1.6: 209-222.Type: articleGastropanel
2017Franceschi M, Panozzo MP, Di Mario F, Tomba F, Sella D, Ferronato A, Antico A, Baldassarre G.A role of GastroPanel in the evaluation of the appropriateness of proton rump inhibitor ((PPI) – therapy prescription in a primary care population. Poster presentation at Fismad congress 2017.Type: abstractGastropanel
2017Panozzo MP, Franceschi M , Baldassarre G, Antico A. Could evaluation of risk factors for autoimmune gastritis play a role in early detection of atrophy? A three years study. Poster presentation at Fismad congress 2017.Type: abstractGastropanel
2017Sebastian S, O`Connor H, Crotty P, Buckley M, O`Morain C. Detection H. pylori Related Gastric Intestinal Metaplasia and Atrophy Using Seromarkers. Helicobacter 2003; Vol 8(4): 424 (A10.20).Type: abstractGastroPanel
2017Maejima R, Iijima K, Kaihovaara P, Hatta W, Koike T, Imatani A, Shimisegawa T, Salaspuro M. Effects of ALDH2 Genotype, PPI Treatment and L-Cysteine on Carcinogenic Acetaldehyde in Gastric Juice and Saliva after Intragastric Alcohol Administration. PLOS ONE 1.4.2015; PLOS ONE | DOI:10.1371/journal.pone.0120397.Type: scientific articleAcetaldehyde
2017Sipponen P., Salaspuro M., Härkönen M.Atrofinen gastriitti. Biomerkkiainetutkimus ja atrofinengastriitti – tärkeä mahalaukun syövän ja B12 vitamiinipuutoksen riskitila.Yksityislääkäri 2008; 3:99-106. 3/2008 sivut 99-106Type: articleGastroPanel
2017Kolesnikova E, Chupin I, Nemtsova VEFFICACY OF SERUM GASTRIN-17, PEPSINOGEN I AND HELICOBACTER PYLORI ANTIBODIES IN NON-ENDOSCOPIC DIAGNOSIS OF MULTIFOCAL ATROPHIC GASTRITIS. Gut 2007; 56(Suppl 3); A97Type: abstractGastroPanel
2017Slăvescu KC, Pirvan A, Gheban D, Eklund C, Hendolin P, Paloheimo L, Syrjänen K.A point-of-care test for anti-transglutaminase (tTG2A) IgA, IgG, IgM antibodies (CELIAC Quick Test®) validated in diagnosis of incident celiac disease (CD) in pediatric patients. EC Gastroenterology and Digestive System 2017; 3 (1): 04-13.Type: scientific articleCeliac disease
2017Tursi A, De Bastiani R, Franceschi ML, Goni E, Riccò M, Venerito M, Rugge M, Scarpignato C, Picchio M, Di Mario F, the Primary Care collaborative group.Non-invasive assessment of gastric secretory function in centenarians. Geriatric Care 2017; 3:6682.Type: scientific articleGastroPanel
2017Zheng KC, Aoki K, Li XQ, Lin SG, Wu BS, Zhong WL, Chen TH, Lin S, You JW, Su CSerum Pepsinogens, Gastrin-17 and Helicobacter pylori Antibody in the Residents of Two Cities with District Mortality Rates of Gastric Cancer. Tohoku J Exp Me 2012; 228(4):289-294.Type: scientific articleGastroPanel
2017Vasilyev S, Smirnova E, Popov D, Semenov A, Eklund C, Hendolin P, Paloheimo L, Syrjänen K. A New-Generation Fecal Immunochemical Test (FIT) is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia among Colonoscopy Referral Patients. Anticancer Res 2015; 35:2873-2880.Type: certificateColonView
2017Syrjänen K.Serological Biomarker Panel (GastroPanel®): A Test for Non-Invasive Diagnosis of Dyspeptic Symptoms and for Comprehensive Detection of Helicobacter pylori Infection. Biomark J. 2017, 3:1. DOI: 10.21767/2472-1646.100024.Type: scientific articleGastroPanel
2017Kokkola A, Sipponen P, Rautelin H, Härkönen M, Kosunen TU, Haapiainen R, Puolakkainen P. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002; 16:515-520.Type: scientific articleGastric disease
2017Aresvuo Ulla Tupakanvierotusmenetelmät, niiden teho, haitta- vaikutukset ja vasta-aiheet, Metropolia Ammattikoulu. Insinööri (AMK). Bio- ja elintarviketekniikka, Insinöörityö. 5.5.2017Type: otherSmoking cessation
2017Salaspuro V, Hietala J, Kaihovaara P, Pihlajarinne L, Marvola M, Salaspuro M.Removal of acetaldehyde from saliva by a slow release buccal tablet of L-cysteine. Int J Cancer 2002; 97:361-364.Type: scientific articleAcetaldehyde
2017Sipponen P, Laxen F, Huotari K, Härkönen M.H.pylori related Atrophic Gastritis is a Common Cause of Low Vitamin B12 and High Homocysteine in Serum in an Elderly Male Population. Helicobacter 2003; Vol 8(4): 398 (A07.01).Type: abstractGastroPanel
2017Sebastian S, McLouglin R, Hall W, Qasim A, O`Connor H, Buckley M, O`Morain CNon-Invasive Methods of Diagnosis of Gastric Intestinal Metaplasia – an Observational Case-Control Study. Gastroenterol 2003; 124 (4)(Suppl 1): A-423 (M2142).Type: abstractGastroPanel
2017Sebastian S, Hall W, Qasim A, McLoughlin R, O`Connor H, Crotty P, Buckley M, O`Morain C Jr.Detection of Premalignant Lesions in First Degree Relatives of Gastric Cancer: Endoscopy or Serodiagnosis? Gastroenterol 2003; 124 (4)(Suppl 1): A-420 (M2126).Type: abstractGastroPanel
2004Salonen E-M, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H.CAntinuclear Antibody Assays in 430 Patients with SLE and Other Rheumatic Diseases (Extended report). Ann Rheum Dis 2004; 63: 1250-1254. Type: scientific articleanti-telomere antibodies
2012Noah Noah D, Okomo Assoumou MC, Bagnaka SAFE, Ngaba GP, Alonge IE, Paloheimo L, Njoya O. Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection. Open Journal of Gastroenterology 2012; 2:113-118.Type: scientific articleGastroPanel
2015Reshetnikov OV, Kurilovich S, Molchanova A.Association of H.pylori with pepsinogen II level. Helicobacter 2010; 15(4):371.Type: abstractGastroPanel
2010Veijola LI, Oksanen AM, Sipponen PI, Rautelin HIK Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.World J Gastroenterol 2010 16(1): 83-88.Type: scientific articleGastric disease
2015Venerito M, Radünz M, Reschke K, Reinhold D, Frauenschläger K, Jechorek D, Di Mario F, Malfertheiner P. Autoimmune gastritis in autoimmune thyroid disease. Aliment Pharmacol Ther 2015; 41: 686–693. Aliment Pharmacol Ther. 2015 Feb 3. doi: 10.1111/apt.13097.Type: scientific articleGastroPanel
2012Rugge M, Fassan M, Pizzi M, Zorzetto V, Maddalo G, Realdon S, De Bernard M, Betterle C, Cappellesso R, Pennelli G, de Boni M, Farinati F. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther. 2012 Jun;35(12):1460-6. doi: 10.1111/j.1365-2036.2012.05101.x. Epub 2012 Apr 22.Type: scientific articlePepsinogen I monoclonal antibody
2015Sipponen P and Maaroos HIChronic gastritis. Scand J Gastroenterol 2015; 50:657-667.Type: scientific articleGastric disease
2010Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis 2010; 29(7):907-11.Type: scientific articleGastroPanel
2017Syrjänen, K. False Positive and False Negative Results in Diagnosis of Helicobacter Pylori Infection Can be Avoided by A Panel of Serum Biomarkers (GastroPanel®). M J Gast 2016. 1(1) 007: 1-7.Type: scientific articleGastropanel
2017Belkovets AV, Reshetnikov OV, Kurilovich SA, Openko TG, Ragino JI, Malyutina SK. Predicting value of serological biomarkers for gastric cancer in Russia: a retrospective cohort study gastric cancer; serology; prediction. Helicobacter 2013; 18(Suppl. 1): 151-152 (P18.08).Type: abstractGastroPanel
2017Franceschi M, Panozzo MP, Messina O, Tomba F, Sella D, Ferronato A, Antico A, Di Mario F, Baldassarre G.SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS. National congress FISMAD 2016, Napels, Italy.Type: abstractGastroPanel
2017Di Mario F, De Bastiani R, Riccò M, Franceschi M, Alberto P, Rugge M, Ptere M.Gastric acid secretion in centenarians assessed by a non-invasive surrogate test. Helicobacter 2016; 21(Suppl 1): 128 (P06.04)Type: abstractHelicobacter
2016Di Mario F, Landi S, Grillo S, Corrente V, Franceschi M, Cannizzaro R, Baldassarre F, Grande G, Rugge M.PPI-test for diagnosis of body atrhopic gastritis: a prospective study. Helicobacter 2016; 21(Suppl 1):128-129 (P06.05)Type: abstractGastric disease
2016Franceschi M, Panozzo M, Ferronato A, Antico A, Tomba F, Di Mario F, Cerofolini A, Morini A, Visona A, Gasparri L, Baldassarre G.Time trends in histological and serological prevalence of Helicobacter pylori infection: focus on a dyspeptic population in a North-East Italy area. Helicobacter 2016; 21(Suppl 1):104 (P02.06)Type: certificatePepsinogen I PPI
2016Syrjänen K, Salminen J, Aresvuo U, Hendolin P, Paloheimo L, Eklund C, Salaspuro M, Suovaniemi O.Elimination of Cigarette Smoke-derived Acetaldehyde in Saliva by Slow-release L-Cysteine Lozenge Is a Potential New Method to Assist Smoking Cessation. A Randomised, Double-blind, Placebo-controlled Intervention. Anticancer Res 2016; 36: 2297-2306.Type: scientific articleAcetium
2016Kari Syrjänen A Panel of Serum Biomarkers (GastroPanel®) in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis. Anticancer Res 2016; 35(10):5133-5144.Type: scientific articleGastropanel
2016Vohlonen I, Pukkala E, Malila N, Härkönen M, Hakama M, Koistinen V, Sipponen PRisk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up. Scand J Gastroenterol 2016; 51(10):1159-1164.Type: scientific articleHelicobacter
2016Roman LD, Lukyanchok R, Sablin OA , Araslanova EI, Eklund C, Hendolin P, Paloheimo L, Syrjänen K. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel ®) in St. Petersburg. Anticancer Res 2016; 36:4129-4138.Type: scientific articleGastroPanel
2016Loor A, Dumitraşcuy DLHelicobacter pylori Infection, Gastric Cancer and Gastropanel. Rom J Intern Med 2016 54(3):151-156. doi: 10.1515/rjim-2016-0025.Type: scientific articleGastropanel
2016Kurilovich S, Belkovets A, Reshetnikov O, Openko T, Malyutina S, Ragino Y, Scherbakova L, Leja M, Paloheimo L, Syrjänen K, Voevoda M. Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia. Anticancer Res 2016; 36(1):247-53.Type: scientific articleGastropanel
2010Linderborg K, Marvola T, Marvola M, Salaspuro M Färkkilä M and Väkeväinen SReducing Carcinogenic Acetaldehyde Exposure in the Achlorhydric Stomach With Cysteine. Alcohol Clin Exp Res 2010; 35(3):516-522.Type: scientific articleAcetaldehyde
2004Salonen E-M, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere Antibodies in Systemic Lupus Erythematosus (SLE): A Comparison with Five Antinuclear Antibody Assays in 430 Patients with SLE and Other Rheumatic Diseases (Extended report). Ann Rheum Dis 2004; 63: 1250-1254.Type: scientific articleanti-telomere antibodies
2011Salaspuro MikkoAcetaldehyde - Specific class 1 carcinogen associating with the use of alcoholic beveragesType: otherAcetaldehyde
2013Jeong Soo Ahn, Chun-Sick Eom, Christie Y Jeon, Sang Min ParkAcid suppressive drugs and gastric cancer: A meta-analysis of observational studiesType: scientific articleGastric disease
2011Suovaniemi, OsmoState of the art GastroPanel and Acetium Innovations for the unmet needType: scientific articleGastric disease
2016BiohitLimitations of Helicobacter pylori diagnosticsType: articleGastroPanel
2017Baldassarre G, Messina O, Panozzo MP, Tomba F, Sella D, Ferronato A, Antico A, Vanzetto E, Toffanin R, Di Mario F, Franceschi M. Improvement of appropriateness of upper GI endoscopy out-patients through selection of patients and introduction of GastroPane : a single-centre prospective study (National congress FISMAD 2016, Napels, Italy)Type: abstractGastropanel
2011Gatta L, Di Mario F, Vaira D, Rugge M, Franzè A, Plebani M, Cavestro GM, Lucarini P, Lera M, Scarpignato C. Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Helicobacter pylori. Clin Gastroenterol Hepatol. 2011; 9(5):440-442.Type: scientific articleGastroPanel
2017Kikuchi R, Abe Y, Iijima K, Koike T, Ara N, Uno K, Asanuma K, Asano N, Imatani A, Shimosegawa T.Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer. Tohoku J Exp Med. 2011; 223(1):35-44.Type: abstractGastroPanel
2011He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y. Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs.J Gastroenterol Hepatol. 2011; 26(6):1039-46Type: scientific articlePepsinogen II
2016Aine R, Kahar E, Aitokari K, Salminen J, Eklund C, Paloheimo L, Peetsalu A, Syrjänen K. Atrophic gastritis (AG) and its clinical sequels among elderly people in Finland and Estonia. A comparative study using GastroPanel and B12- vitamin testing of the residents in assisted-housing facilities. J Aging Res Clin Practice 2016;5(4):194-202.Type: scientific articleGastroPanel
2017Peitz U, Wex T, Vieth M, Stolte M, Willich S, Labenz J, Jaspersen D, Lind T, Malfertheiner P.Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. J Gastroenterol Hepatol 2011; 26(1):82-89.Type: scientific articleGastroPanel
2010Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R, Torchio B.Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med 2010; 48(9):1327-32Type: scientific articleGastroPanel
2004Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB Mernova VP. The non-invasive diagnosis of precancerous changes of stomach mucosa . Annales Academiae Medicae Bialostocensis, Roczniki Akademii Medycznej w Bialymstoku 2004; 49:66-71.Type: scientific articleGastroPanel
2017Di Mario F, Panozzo MP, Baldassarre G, Antico A, Tursi A, Brandimarte G , Scarpignato C, Franceschi M. The branded proton pump inhibitors (PPIs) increase levels of gastrin 17 (G17) more than the generic ones in dyspeptic patients from an Italian primary care population. Poster presentation at Fismad congress 2017.Type: abstractGastroPanel
2017Kuokkanen M, Myllyniemi M, Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Karesvuori S, Linnala A, Harkonen M, Jarvela I.A quick test for perendoscopic diagnosis of hypolactasia from postbulbar duodenal biopsy. Gut 2004; 53(Suppl VI): A284 (WED-G-266).Type: abstractLactose Intolerance
2009van Marrewijk CJ, van Oijen MG, Paloheimo LI, Fransen GA, Mujakovic S, Muris JW, Numans ME, de Wit NJ, Grobbee DE, Knottnerus JA, Laheij RJF, Jansen JB. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Aliment Pharmacol Ther. 2009; 30(1):82-9.Type: scientific articleGastroPanel
2013Benberin V, Bektayeva R, Karabayeva R, Lebedev A, Akemeyeva K, Paloheimo L, Syrjänen K.Prevalence of H. pylori Infection and Atrophic Gastritis Among Symptomatic and Dyspeptic Adults in Kazakhstan. A Hospital based Screening Study Using a Panel of Serum Biomarkers. ANTICANCER RESEARCH 2013; 33: 4595-4602.Type: scientific articleGastroPanel
2017Ferrara F, Dal Bò N, Furlanetto A, Dei Tos AP, Slongo T, Loperfido S, Heras Salvat H, Scarpignato C. GASTROPANEL AND OLGA: TWO INNOVATIVE TOOLS FOR THE DETECTION OF ATROPHIC GASTRITIS. A PROSPECTIVE STUDY IN PRIMARY CARE. Gut 2012; 61 (Suppl 3): A205 (P0478).Type: abstractGastroPanel
2017Di Mario F, Moussa AM, Caruana P, Cavallaro LG, Cavestro GM, DalBò N, Iori V, Pilotto A, Leandro G, Franze A, Rugge M. ”Serological Biopsy” in First Degree Relatives of Patients with Gastric Cancer, Affected by Helicobacter pylori. Helicobacter 2003; Vol 8(4): 402 (A07.13)Type: abstractGastroPanel
2017Vohlonen IJ. ESOPHAGEAL, GASTRIC AND DUODENAL DISORDERS GASTRIC SPECIFIC BIOMARKER BASED SCREENING FOR RISK OF STOMACH CANCER. J Gastroenterol Hepatol 2013:28 (Suppl. 3):309 (P0749).Type: abstractGastroPanel
2011Koumi A, Filippidis T, Leontara V, Makri L, Panos MZDetection of Helicobacter pylori: A faster urease test can save resources. World J Gastroenterol. 2011 Jan 21;17(3):349-53.Type: scientific articleHelicobacter pylori Quick Test
2017Cavallaro LG, Moussa AM, Seghini P, Aragona G, Iori V, Cavestro GM, Dal Bo N, Pilotto A, Di Mario F. Topoghraphy of Gastric Damage in H. pylori Infection: Evaluation by Serum Pepsinogen Levels. Gut 2002; Suppl II Vol 51: A30Type: abstractGastroPanel
2017Kuokkanen M, Myllyniemi M, Vauhkonen M, Kääriäinen I, Karesvuori S, Linnala A, Härkönen M, Järvelä I, Sipponen PA biopsy-based guick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy 2006;38(7):708-712.Type: scientific articleLactose Intolerance
2014Kayamba V, Chomba M, Kelly P. Short term micronutrient-antioxidantsupplementation has no impact on a serological marker of gastric atrophy in Zambian adults:retrospective analysis of a randomised controlled trial. BMC Gastroenterol 2014; 14:52.Type: scientific articlePepsinogens
2015Gou Y, Wang W, Jin A, Chen H, He W, Huang X. Diagnostic Values of Serum Pepsinogens, Gastrin 17 and Helicobacter pylori IgG Antibodies for Atrophic Gastric or Gastric Cancer Patients Screening in a high risk area in China. UEGW 2015. Poster presentation P1790.Type: abstractGastroPanel
2010Pimanov SI, Makarenko EV, Ruselik EV. H.pylori eradication improves serological diagnosis of atrophic gastritis in patients with duodenal ulcer. Helicobacter 2010;15(4):354.Type: abstractGastroPanel
2017Sipponen P, Härkönen M. Kirjeitä ja mielipiteitä. Dyspepsiasuositus viime vuosituhannelta? Duodecim 2013;129:265–266.Type: articleGastric disease
2006Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12(44):7172-7178Type: scientific articleGastroPanel
2015Di Mario F, Goni E, Franceschi M, Baldassarre G, Cannizzaro R, Dal Bo N, Corrente V, Bertelè A, Venerito M, Malfertheiner P, Scarpignato C, Rugge M. DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS. UEGW 2015 Poster presentation P1095.Type: abstractGastroPanel
2005Di Mario F, Ingegnoli A, Altavilla N, Cavallaro LG, Bertoloni S, Merli R, Cavestro GM, Iori V, MAino M, Leandro G, Franzé A. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundamental & Clinical Pharmacology 2005: 19;497-501. Type: scientific articleGastroPanel
2009Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol. 2009; 44(5):564-70.Type: scientific articleGastroPanel
2017Rehfeld JF, Gingras MH, Bardram L, Hilsted L, Goetze JP, Poitras P. The Zollinger-Ellison syndrome and mismeasurement of gastrin. Gastroenterology. 2011 May;140(5):1444-53.Type: scientific articleGastrin
2005Nurgalieva Z.Z, El-Zimaity H.M, Graham D.Y, Campos A, Guerrero L, Chavez A, Opekun A.R, Cardenas V. Gastric in North America: Histology Vs. Non-Invase Testing. Gastroenterology 2005; 128 (4, Suppl 2): A-291Type: abstractGastroPanel
2017de Korwin J-D, Prucha V, Lozniewski A, Vignaud J-M, Conroy MC, Legoedec J. Non endoscopic diagnosis of atrophic gastritis using the GastroPanel/GastroSoft. Presentation at the workshop organised by French Helicobacter Study Group on Jan 28th 2005 in FranceType: abstractGastroPanel
2017Sipponen P, Linnala A, Väänänen H, Rasmussen, Tunturi-Hihnala H, Sotka M, Turunen M, Sandström R, Heiskanen I, Härkönen M, Suovaniemi O.Helicobacter Pylori Infection and Related Risks and Diseases - Towards Optimal Diagnostics and Evidence Based Medicine. Presentation at the 5th Nordic-Baltic Congress on Infectious Diseases, 22-25 May 2002, Saint-Petersburg, Russia.Type: abstractGastroPanel
2017Ferrara F, Dal Bò N, Slongo T, Rigoli R, Caroli A, Heras Salvat H, Marcello R, Scarpignato C, Savarino V, Di Mario F. Low Levels of Gastrin-17 As a Non-Invasive Marker of GERD. Gastroenterology 2013;144 (5): S-858 (Tu1837). DDW 2013 poster abstract; Tu1834 (A-1400).Type: abstractGastrin 17
2017Cavallaro L, Moussa AM, Merli R, Iori V, Cavestro GM, Cerati E, Altavilla N, Dal Bó N, Rugge M, Colla G, Bertele' A, Franzé A, Francesco Di Mario. Serum Pepsinogen II for Early Assessment of Success of H. Pylori Eradication. Gastroenterol 2003; 124 (4)(Suppl 1): A-179 (S1238).Type: abstractPepsinogen II
2017Ferrara F, Dal Bò N, Dei Tos AP, Furlanetto A, Slongo T, Heras Salvat H, Marcello R, Loperfido S, Caroli A, Scarpignato C, Rugge M, Di Mario M. GastroPanel and OLGA: Two Innovative Tools for the Detection of Atrophic Gastritis. A Prospective Study in Primary Care. Gastroenterology 2013;144 (5): S-349 (Sa1976). DDW 2013 poster abstract; Sa1976 (A-557).Type: abstractGastroPanel
2017Leja M, Meri HA, Vaivade I, Vanags A, Kikuste I, Kojalo U, Klovins J. The Performance of Diagnostic Tests for Adult-Type Hypolactasia. Gastroenterology 2011; 140 (5): S-89 (Lecture 443 at DDW 2011.Type: scientific articleLactose Intolerance
2017Redeén S, Petersson F, Paloheimo L, Borch K. Relations of Circulating Levels of Vitamin B12, Folate and Homocysteine to Gastritis and H. pylori Infection in a Sample of the General Population. Helicobacter 2003; Vol 8(4): 403 (A07.14)Type: abstractGastroPanel
2017Cavallaro LG, Moussa AM, Caruana P, Merli R, Cavestro GM, Liatopoulou S, Maino M, Iori V, Marcucci F, Corrente V, Franze A, Di Mario F.Diagnosis of H. pylori Gastritis Patterns by Means of GastroPanel. Helicobacter 2003; Vol 8(4): 383 (A05.05).Type: abstractGastroPanel
2017Franceschet I, Ferrara F, Rigoli R, Pascoli S, Slongo T, Dal Bò N, Caroli A, Marcello R, Scarpignato C, Schiavinato A, Di Mario F. GASTROPANEL, A NON-INVASIVE SAVE-ENDOSCOPY METHOD: A PROSPECTIVE 1000 PATIENTS STUDY IN PRIMARY CARE SETTING. Gut 2012; 61 (Suppl 3): A439 (P1610).Type: abstractGastroPanel
2017Cavallaro LG, Moussa AM, Caruana P, Merli R, Bertolini S, Iori V, Cavestro GM, Muzzetto P, Liatopoulou S, Dal Bò N, Di Mario F.Oral Sucrose Test and Serum Pepsinogens for Evaluation of H. pylori Chronic Gastritis. Helicobacter 2003; Vol 8(4): 384 (A05.06).Type: abstractGastroPanel
2017Di Mario F, Dal Bò N, Ferrara F, Slongo T, Heras H, Caroli A, Loperfido S, Marcello R, Schiavinato A, Scarpignato C. Is H. pylori eradication useful in the improvement of dyspepsia?: a 15 years study. Gut 2012; 61 (Suppl 3): A210-211 (PO504).Type: abstractGastroPanel
2017Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue Jr. TM, Kharbanda K, Cruz M, Opris M.Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp Mol Pathol 2017;102(1):168-180.Type: scientific articleGastric disease
2007Minushkin OV, Zverkov IV, Topchii TB, Volodin PV, Shuleshova AGChronic autoimmune gastritis: diagnosis and features of the disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A101.Type: scientific articleGastroPanel
2009AH Poulsen, S Christensen, JK McLaughlin, RW Thomsen, HT Sørensen, JH Olsen and S FriisProton pump inhibitors and risk of gastric cancer: a population-based cohort study. British Journal of Cancer 2009; 100:1503–1507.Type: scientific articleGastric disease PPI
2006Sipponen PBiomarkers in Clinical practice: a tool to find subjects at high risk fro stomach cancer. A personal view. Advances in Medical Sciences 2006;51;51-53Type: scientific articleGastroPanel
2016Vohlonen I, Härkönen M, Malila N, Pukkala E, Sipponen P, Koistinen K, Hakama M. Challenges in evaluation of screening for gastric cancer among men based on nonrandomized design , Acta Oncologica 2017. DOI:10.1080/0284186X.2016.1278304Type: scientific articleGastroPanel
2017Pimanov SI, Makarenko EV, Voropaeva AV, Matvienko, Voropaeva EV. Prerequisites for Empirical Eradication Therapy in patients with Duodenal Ulcer: Study in Belarus. Helicobacter 2003; Vol 8(4):475.Type: abstractGastroPanel
2017 Ancans G, Liepniece-Karele I, Sivins A, Skapars R, Rudzite D, Lasina I, Eglitis J, Leja M. CELLULAR FIBRONECTIN IN GASTRIC CANCER PATIENTS WITH KNOWN HELICOBACTER PYLORI INFECTION STATUS. Helicobacter 2012: 17 (Suppl. 1); 112 (P5.10)Type: abstractcellular fibronectin
2007Ojetti V, La Mura R, Zocco MA, Cesaro P, De Masi E, La Mazza A, Cammarota G, Gasbarrini G, Gasbarrini A. Quick test: a new test for the diagnosis of duodenal hypolactasia. Dig Dis Sci. 2008 Jun;53(6):1589-92.Type: scientific articleLactose Intolerance
2017Sundelin H, Hendolin P, Paloheimo L, Kaihovaara P, Kronberg L, Salaspuro M. M. L-CYSTEINE (ACETIUM) LOZENGE EFFECTIVELY ELIMINATES CARCINOGENIC ACETALDEHYDE FROM SALIVA. Poster presentation at ESBRA 2015.Type: abstractAcetaldehyde Acetium
2007van Oijen MGH, Sipponen P, Laheij RJF, Verheugt FWA, Jansen JBMJ. Gastric status and vitamin B12 levels in cardiovascular patients. Dig Dis Sci 2007; 52(9):2186-2189.Type: scientific articleGastroPanel
2017Sipponen P, Härkönen M. Terveydenhuolto-katsaus. Mahalaukun biomerkkiainetutkimukset tuovat kustannussäästöjä. Yleislääkärilehti 2009; 8:23-25.Type: scientific articleGastroPanel
2017Gatta L, Di Mario F, Vaira D, Rugge M, Franzé A, Plebani M, Cavestro GM, Lucaraini P, Lera M, Scarpignato CDiagnostic accuracy of serum pepsinogens and gastrin to follow-up Helicobacter pylori infection. UEGW 2010. P0303Type: abstractGastroPanel
2016Sipponen P, Maaroos HI. Krooniline gastriit (in Estonian). Eesti Arst 2016;95(10):637-643.Type: scientific articleAtrophic Gastris
2014Di Mario F, Goni E. Misleading results in the diagnosis of atrophic gastritis. Eur J GastroenterolHepatol 2014, Vol 26 No 12Type: scientific articleGastroPanel
2006Sun LP, Gong YH, Wang L, Gong W, Yuan Y. Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county. Zhonghua Yi Xue Za Zhi. 2006 Oct 31;86(40):2826-30. [Article in Chinese].Type: scientific articleGastroPanel
2015Venerito M, Varbanova M, Röhl F, Reinhold D, Frauenschläger K, Weight J, Link A, Malfertheiner P. Oxyntic gastric atrophy in autoimmune gastritis compared to Helicobacter pylori gastritis. Poster presentation P01.17 at European Helicobacter Study Group 2015 congress. Helicobacter 2015:20(Suppl. 1); 90.Type: abstractGastroPanel
2007Zhang Z, Sun LP, Gong YH, Wang XG, Zhang M, Yuan YFactors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese. J Dig Dis 2007; 8:72-76.Type: scientific articleGastroPanel
2017Storskrubb T, Aro P, Ronkainen J, Talley N, Stolte M, Vieth M, Sipponen P, Agréus L. Diagnosis of atrophic corpus gastritis by serological biomarkers. Evaluation in a large population sample (The Kalixanda Study). Presentation at the World Congress of Gastroenterology September 12-14 2005, Montreal, Canada.Type: abstractGastroPanel
2014Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja MGastric cancer: Prevention, screening and early diagnosis World J Gastroenterol 2014; 20(38):13842-62.Type: scientific articleGastroPanel
2017Sulin MSyöpää torjuvan kapselin keksijä. Iltalehti 30.1.2010:22-23.Type: articleAcetaldehyde
2005Germana B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel B, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franz´e A. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 2005; 37:501–508.Type: scientific articleGastroPanel
2017Tsukanov VV, Amelchugova OS, Vasyutin AV, Tretyakova OV. Prevalence and Risk Factors of Uninvestigated Dyspepsia and Atrophic Gastritis in the Urban Population of Siberia Over 45 Years Old. Gastroenterology 2012; 142 (5): S-467 (Su1627). A poster presentation at DDW 2012: Su1627, A-752.Type: abstractGastroPanel
2017Makarenka A, Pimanov S, Voropaeva A, Voropaev E. High prevalence of Helicobacter pylori infection and multitude of vacAM and vacAs Helicobacter pylori strains in patients with peptic ulcer: Study in Belarus. Presented at Gastroenterology Week Freiburg, Oct 16-17, 2004.Type: abstractGastroPanel
2017Amiriani T, Kelarijani FN, Besharat S, Roshandel G. Validity of Serum Markers As Non-Endoscopic Screening Method for Gastric Cancer. Gastroenterology 2014; 146 (5): S-337 (Sa1949). DDW 2014 poster presentation Sa1949.Type: abstractGastroPanel
2017Gatta L, Di Mario F, Vaira D, Rugge M, Scarpignato C, Malfertheiner P, Venerito M, Cavestro GM, Franzé A.Diagnostic accuracy of serum pepsinogens and gastrin to follow-up Helicobacter pylori infection: a pilot study. Gastroenterology 2010; 138 (5): S-340 (M1141). DDW 2010 poster presentation M1141.Type: abstractGastroPanel
2013Leja M, Funka K, Janciauskas D, Putnins V, Ruskule A, Kikuste I, Kojalo U, Tolmanis I, Misins J, Purmalis K, Pimanov S, Makarenko J, Kupcinskas L, Vikmanis U. Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol 2013; 25(6):694-699. doi: 10.1097/MEG.0b013e32835e3397.Type: scientific articleGastric disease
2017Di Mario F, Cavallaro L.G, Liatopoulou S, Moussa A, Maini A, Bertolini S, Merli R, Dal Bò N, Iori V, Stefani N, Cavestro G.M, Marcucci F, Rugge M, Franzè A.Accurancy of "serological gastric biopsy" in a cohort of dyspeptic patients. Gastroenterology 2005; 128 (4), Suppl 2).Type: abstractGastroPanel
2017Di Mario F, Grillo S, Landi S, Grande S, Riccò M, Franceschi M, Baldassarre F, Cannizzaro R, Nadia D, Gnocchi A, Corrente V, Bertelè A, Rugge M. Recovery of gastric function in chronic atrophic gastritis: a 3 years study. Helicobacter 2016; 21(Suppl 1):88-89(W5.5). Lecture.Type: abstractGastroPanel
2016Agreus L, Hellström PM, Talley NJ, Wallner B, Forsberg A, Vieth M, Veits L, Björkegren K, Engstrand L, Andreasson A. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. UEG J 2016; 4(5): 686–696. DOI: 10.1177/2050640615623369.Type: scientific articleHelicobacter
2017Linderborg K, Marvola T, Marvola M, Salaspuro M, Färkkilä M, Väkeväinen S.Reducing carcinogenic acetaldehyde exposure in the achlorhydric stomach with cysteine. Alcohol Clin Exp Res 2011 Mar;35(3):516-22.Type: scientific articleAcetaldehyde
2016BiohitAcetiumType: articleAcetium
2016BiohitMigraineType: articleAcetium
2016BiohitOral cancerType: articleAcetium
2016BiohitAutoimmune screening panelType: articleGastroPanel
2016K. SyrjänenCaveats in Diagnosis of Helicobacter Pylori Infection can be Avoided by a Panel of Serum Biomarkers (GastroPanel®)Type: scientific articleGastropanel
2016BiohitBiohit products and services for unmet needType: brochureProducts
2016Syrjänen, K. Caveats in Diagnosis of Helicobacter Pylori Infection can be Avoided by a Panel of Serum Biomarkers (GastroPanel®). Carcinog Mutagen 2016; 7(6):1-3.Type: scientific articleGastropanel, Helicobacter
2010Song HJ, Jang SJ, Yun SC, Park YS, Kim MJ, Lee SM, Choi KD, Lee GH, Jung HY, Kim JHLow Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy. Gut Liver 2010; 4(4):475-80.Type: scientific articleGastroPanel
2016Syrjänen K, Eronen K. Serological Testing in Management of Dyspeptic Patients and in Screening of Gastric Cancer Risks. J Gastrointest Disord Liver Func 2016Type: scientific articleGastric disease
2017Talebkhan Y, Ebrahimzadeh F, Farjaddoost A, Aghalaie A, Morakabati A, Nahvijou A, Mohammadi M.Serum pepsinogen levels in developing gastric cancer screening approaches among Iranian high risk populations. Helicobacter 2011; 16(Suppl 1):112.Type: abstractPepsinogens
2016Hellström PM, Hendolin P, Kaihovaara P, Kronberg L, Meierjohann A, Millerhovf A, Paloheimo L, Sundelin H, Syrjänen K, Webb D-L, Salaspuro MSlow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis. Scand J Gastroenterol 2017; 52 (2):230-237.Type: scientific articleAcetaldehyde Acetium
2016Kotelevets SM, Galeeva ZM, Karakotova ZB, Chekh SANovel information on the genetic factors involved in the development of diseases. Eur Rev Med Pharmacol Sci 2016; 20 (17): 3672-3678Type: scientific articleGastroPanel
2016Venerito M, Varbanova M, Röhl F-W, Reinhold D, Frauenschläger K, Jechorek D, Weigt J, Link A, Malfertheiner POxyntic Gastric Atrophy in Helicobacter Pylori Gastritis Is Distinct From Autoimmune Gastritis. J Clin Pathol. 2016;69(8):677-685.Type: scientific articleGastroPanel
2016De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R.Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer. Clin Transl Gastroenterol. 2016 Jul 21;7(7):e183. doi: 10.1038/ctg.2016.42.Type: scientific articleGastroPanel
2016Salaspuro M.Elintarvikkeiden ja alkoholijuomien turvallisuutta valvovien viranomaisten uskottavuus horjuu. Kirjeitä ja mielipiteitä. Duodecim 2016;132:2363–4.Type: articleAcetaldehyde
2017Mecklin JP, Ristimäki A, Sipponen P, Nuorva K, Kärjä V, Sarna S, Renkonen-Sinisalo L, Aarnio M, Heikkinen M, Pylvänäinen K, Järvinen HJ. SEROLOGICAL MARKERS IN EVALUATION OF INDIVIDUAL RISK OF GASTRIC CANCER AMONG MUTATION CARRIERS IN LYNCH SYNDROME. Congress abstract 2012, DüsseldorfType: abstractGastroPanel
2017Salaspuro M. Elintarvikeperäinen asetaldehydi on potentiaalinen terveysriski.Pääkirjoitus. Duodecim 2010;126:1651-1653.Type: scientific articleAcetaldehyde
2005Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Varvara P. Mernova VP, Polyakova MB.Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: A comparative study. Scand J Gastroenterol, 2005; 40: 297-301.Type: scientific articleGastroPanel
2016Ricanek P, Vatn S, Lindahl T, Ciemniejewska E, Jahnsen J, Casen C, Vatn MHMicrobiota profiles in treatment-naïve Norwegian IBD and non-IBD patients: part of the European Union IBD character consortium. Congress presentation DOP089 at ECCO 2016 in Amsterdam, the Netherlands.Type: abstractMicrobiota
2011Novikova VP, Sidorkin AO, Anichkov NM, Azanchevskaia SV. Morpho-functional peculiarities of autoimmune gastritis in different age groups. Eksp Klin Gastroenterol. 2011;(5):26-30. [Article in Russian].Type: scientific articleGastroPanel
2014Tursi A, Grattagliano I, De Polo M, Pirrotta E, Bacchin P, Picchio M, De Bastiani R. Noninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care. Scand J Gastroenterol. 2014; 49(11):1394-1396.Type: scientific articleGastric disease
2013Adamczyk M , Peczek Ł, Rudnicki C, Nawrot B, Stec-Michalska K. Pol Merkur Lekarski.Pol Merkur Lekarski. The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer. Pol Merkur Lekarski 2013; 35(207):141-147. [ArticleType: scientific articleGastroPanel
2012Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, Sung J. Rationale in diagnosis and screening of atrophic gastritis with stomach specific plasma biomarkers. Scand J Gastroenterol 2012; 47:136-147.Type: scientific articleGastroPanel
2015Di Mario F, Goni E, Dal Bo N, Ferrara F, Marcello R, Grande G, Franceschi M, Ricco M, Scarpignato C, Rugge M. RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM_ ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS. W5.6 Presentation at European Helicobacter Study Group 2015 congress. Helicobacter 2015: 20(Suppl.1);83Type: abstractAcetium GastroPanel
2015Goni E, Franceschi M, Scarpignato C, Rugge M, Di Mario F.RELATIONSHIP BETWEEN GASTROPANEL AND O.L.G.A IN THE DETECTION OF CHRONIC ATROPHIC GASTRITIS IN A PRIMARY CARE SETTING. UEGW 2015 Poster presentation P0514.Type: abstractGastroPanel
2015McNicholl AG, Valle J, Gisbert JP. Response to: Accuracy of GastroPanel test in detection of atrophic gastritis. Eur J Gastroenterol Hepatol 2015; 27:105-106.Type: scientific articleGastroPanel
2010Pomytkina TEResults of evaluating the functional state of the gastric mucosa in duodenal peptic ulcer by means of a test GastroPanel in workers engaged in the manufacture of nitrogen compounds. Ter Arkh. 2010; 82(2):17-20. [Article in Russian].Type: scientific articleGastroPanel
2015McNicholl AG, Gisbert JP. Response to: Misleading results in the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2015, 27:104.Type: scientific articleGastroPanel
2017Moussa AM, Germana B, Liatopoulou S, Comparato G, Carloni C, Lecis P, Bertiato B, Doglioni C, Aragona G, Cavallaro LG, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Biedo FC, DiMario F, Franzè A. Screening of Gastric Atrophy by GastroPanel in primary care. Gut 2004; 53 (Suppl VI): A 121 (MON-G-241).Type: abstractGastroPanel
2008Maev IV, Mel'nikova EV, Kashin SV, Nadezhin AS, Kriukova TV. Serologic screening for preneoplastic pathology and early stomach cancer. Klin Med (Mosk). 2008;86(11):43-8. [Article in Russian].Type: scientific articleGastroPanel
2015Kotelevets SM, Chekh SA. Serological Criteria for Mild, Moderate and Severe Atrophy in Atrophic Gastritis. Biol Med 2015; 7: 235Type: scientific articleGastroPanel
2012Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H.Serum pepsinogen test for early detection of gastric cancer in a European Country. Eur J Gastroenterol Hepatol 2012; 24(1):37-41.Type: scientific articleGastroPanel
2009Kamangar F, Diaw L, Wei WQ, Abnet CC, Wang GQ, Roth MJ, Liu B, Lu N, Giffen C, Qiao YL, Dawsey SM. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 2009: 124(2);456-60.Type: scientific articleGastroPanel
2004Salaspuro V, Salaspuro M. Synergistic effect of alcohol drinking and smokingon in vivo acetaldehyde concentration in saliva. Int J Cancer 2004; 111:480-483.Type: scientific articleAcetaldehyde
2014Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Long Q, Flanders WD, Bostick RM, Yuan Y. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer. 2015 Jan 15;136(2):425-34.Type: scientific articleGastroPanel
2004Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB Mernova VP. The non-invasive diagnosis of precancerous changes of stomach mucosa . Annales Academiae Medicae Bialostocensis, Roczniki Akademii Medycznej w Bialymstoku 2004; 49:66-71. Type: scientific articleGastroPanel
2013George DA, Hui LL, Rattehalli D, Lovatt T, Perry I, Green M, Robinson K, Walters JRF, Brookes MJ. The role of near-patient coeliac serology testing in the follow-up of patients with coeliac disease. Fl Gastro Sept 2013 online doi:10.1136/flgastro-2013-100342Type: scientific articleCeliac Disease
2010Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver 2010;4:307-19.Type: scientific articlePepsinogen
2009Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kiudelis G, Chiu H-M, Lin J-T. The Validity of a Biomarker Method for Indirect Detectionof Gastric Mucosal Atrophy Versus Standard Histopathology. Dig Dis Sci 2009; 54(11):2377-84.Type: scientific articleGastroPanel
2014Zhang XM, Li JX, Zhang GY, Li XH, Gu H.The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterology 2014, 14:3 (doi:10.1186/1471-230X-14-3)Type: scientific articleGastric disease
2007de Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, Bizzarri B, Merli R, Comparato G, Caruana P, Cavestro GM, Franzé A, Di Mario F. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Dig Dis. 2007;25(3):206-13.Type: scientific articleGastroPanel
2005Di Mario F, Cavallaro LC, Moussa AM, Caruana P, Merli R, Maini A, Bertolini S, Dal B´o N, Rugge M, Cavestro GM, Aragona G, Plebani M, Franz´e A, Nervi G. Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: RelationshipWith Inflammation, Activity, and Density of the Bacterium. Dig Dis Sci 2006; 51:1791–1795.Type: scientific articleGastroPanel
2011Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas AValue of gastrin-17 in detecting antral atrophy. Advances in Medical Sciences 2011; 56:145-150.Type: scientific articleGastroPanel
2017Syrjänen K, Slow-Release L-Cysteine (Acetium®) Lozenge is an Effective New Method in Smoking Cessation. A randomised, double-blind, placebo-controlled intervention. AntiCancer Research 2017;37:3639-3648.Type: scientific articleAcetaldehyde
2017Mecklin JP, Ristimäki A, Sipponen P, Nuorva K, Kärjä V, Sarna S, Renkonen-Sinisalo L, Aarnio M, Heikkinen M, Pylvänäinen K, Järvinen HJ. SEROLOGICAL MARKERS IN EVALUATION OF INDIVIDUAL RISK OF GASTRIC CANCER AMONG MUTATION CARRIERS IN LYNCH SYNDROME. InSIGHT 2009, DüsseldorfType: abstractAcetaldehyde Acetium
2017Sablin OA, Jurin M, Zakharova N, Simanenkov V. Efficiency of Eradication Therapy in Patients With Autoimmune Gastritis Associated With Helicobacter pylori: A Prospective Study. Gastroenterology 2014; 146(5):S-399 (Su1193). DDW 2014 poster abstract; Su1193 (A-646). Type: abstractGastric Disease
2017Hellström PM, Hendolin PH, Kaihovaara P, Kronberg L, Meierjohann A, Millerhovf A, Paloheimo LI, Sundelin H, Syrjänen KJ, Webb D-L, Salaspuro M . L-Cysteine Slow-Release Capsule Formulation in Prevention of Gastric Carcinogenesis Associated With Atrophic Gastritis. Gastroenterology 2014; 146(5):S-315 (Sa1863).  DDW 2014 poster abstract Sa1863 (A538).Type: abstractAcetaldehyde Acetium
2017Nurgalieva Z.Z, Opekun A.R, Conner M.E, Graham D.Y.Serum Pepsinogens in the Diagnosis of Acute Helicobacter Pylori Infection. Gastroenterology 2005; 128 (4, Suppl 2): A-562.Type: abstractGastroPanel
2017Nurgalieva Z.Z, El-Zimaity H.M, Graham D.Y, Campos A, Guerrero L, Chavez A, Opekun A.R, Cardenas V. Gastric in North America: Histology Vs. Non-Invase Testing. Gastroenterology 2005; 128 (4, Suppl 2): A-291.Type: abstractGastroPanel
2017Tsukanov V, Vasyutin A, Amelchugova O, Tretyakova O. The prevalence of peptic ulcer disease and Helicobacter pylori infection in the urban population of Siberia over 45 years old. Helicobacter 2012: 17 (Suppl. 1); 86 (P2.02)Type: abstractGastroPanel
2017Ignatenko O, Batpenov N, Boretskaya E. ‘Gastropanel' application experience in examining patients with stomach diseases. Helicobacter 2013; 18(Suppl. 1): 137 (P11.46). Type: abstractGastroPanel
2017Kotelevets SM, Chekh SAA comparative study of two methods of serological screening of atrophic gastritis. Research Article. Biol Med 2014; 6(4): 1-10.Type: scientific articleGastroPanel
2017Perets TT, Shporn E, Aizic S, Kelner Y, Levy S, Niv Y, Dickman R. A Diagnostic Approach to Patients With Suspected Lactose Malabsorption. Gastroenterology 2014; 146(5):S-706 (Mo1975). DDW 2014 poster abstract Mo1975 (A-1161).Type: abstractLactose Intolerance
2017Di Mario F, Ferrara F, Dal Bò N, Slongo T, Caroli A, Guarnieri G, Marcello R, Heras Salvat H, Loperfido S, Savarino V, Scarpignato C.A New Approach to Detection of Non-Responder Patients in GERD by Non-Invasive Markers. Gastroenterology 2013;144 (5): S-856 (Tu1825). DDW 2013 poster abstract; Tu1825 (A-1398).Type: abstractGastroPanel
2008German SV. About early preclinical diagnosis of gastroduodenal pathology upon exposure to environmental factors. Gig Sanit. 2008 Nov-Dec;(6):61-4. [Article in Russian].Type: scientific articleGastroPanel
2017Cavallaro LG, Moussa AM, Liatopoulou S, Comparato G, Bertolini S, Merli R, Dal Bo N, Maino M, Bosi S, Cavestro GM, Prati B, Nervi G, Rugge M, Franzé A, DiMario F. Accuracy of "serological gastric biopsy" in a cohort of dyspeptic patients. Presentation at the 6th European Bridging Meeting in Gastroenterology, Kaunas, Lithuania, Nov 26-27, 2004Type: abstractGastroPanel
2017McNicholl AG, Forne M, Barrio J, de la Coba C, Gonzales B, Rivera R, Esteve M, Fernandez-Bañares F, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras C, Esteban C, Santolariaa S, Gomollon F, Valle J, Gisbert JB. On behalf of theAccuracy of GastroPanel for non invasive diagnosis of atrophic gastritis. Helicobacter 2009;14(4):315-316 (W1.5).Type: abstractGastroPanel
2017Zagari RM, Eusebi LH, Rabitti S, Bazzoli F. Accuracy of GastroPanel for the Diagnosis of Atrophic Gastritis: a Meta-Analysis. Gastroenterology 2012; 142 (5): S-403 (Su1025). Poster presentation at DDW 2013_ Su1025.Type: abstractGastroPanel
2017Syrjänen KJ, Sipponen P, Härkönen M, Peetsalu A, Korpela S. Accuracy of the GastroPanel test in the detection of atrophic gastritis. Eur J Gastroenterol Hepatol 2015, 27:102–103.Type: scientific articleGastroPanel
2017McNicholl AG, Ducons J, Barrio J, Bujanda L, Forné-Bardera M, Aparcero R, Ponce J, Rivera R, Dedeu-Cuso JM, Garcia-Inglesias P, Montoro M, Bejerano A, Ber-Nieto Y, Madrigal B, Zapata E, Loras-Alastruey C, Castro M, Nevarez A, Mendez I, Bory-Ros F, MiquelAccuracy of Ultra-Rapid Urease Test for the diagnosis of H. pylori infection. Helicobacter 2010; 15(4):360Type: abstractHelicobacter
2017Malfertheiner P, Selgrad M, Wex T, Del Giudice G, Palla E, Graham D, Heaton PM. Acute Infection with a cagA Positive H. Pylori Strain in Healthy Subjects - Effect On Symptoms and Gastric Physiology. Gastroenterology 2011; 140 (5): S-86 Lecture 432 at DDW 2011.Type: abstractGastroPanel
2017Arinton IG. Adjustment of cut-off values in ELISA for detection of Helicobacter pylori infection. Acta Med Indones. 2011 Apr;43(2):88-91.Type: scientific articleHelicobacter pylori igG
2015Saarikko M.Asetaldehydi on yhä kuuma peruna, Kemia 2015; 8:14-17.Type: articleAcetaldehyde
2017Fock KM, Dhamodaran S, Tiing LA, Eng KT, Song L, Jessica T, Kieron BL. Assessment of serum pepsinogens using commercial ELISA test kit for predicting histology in a Chinese population with intermediate cancer risk. Gastroenterology 2010; 138 (5): S-485 (T1087). DDW 2010 poster presentation T1087Type: abstractGastroPanel
2017Okomo Assoumou MC, Noah Noah D, Ngaba GP, Eloumou Bagnaka SAF, Alonge IE, Paloheimo LI, Njoya OAssociation between the immune responses against Helicobacter pylori infections and the concentration of atrophic gastric biomarkers in Cameroon. Journal Applied Medical Sciences 2012; 1(1):15-26.Type: scientific articleGastroPanel
2017Merli R, Iori I, Curlo M, Guida L, Cavallaro L, Bertelè A, Franzè A, Di Mario F. Association of pepsinogens II (sPGII) and antibodies anti-H. pylori (IgG-Hp) in the evaluation of H. pylori status:comparison with Urea Breath Test. Helicobacter 2008; 13(5):456 (P116).Type: certificateGastroPanel
2017Vanaga V, Daugule I, Moisejevs G, Rudzite D, Krotov S, Janciauskas D, Liepniece-Karele I, Isajevs S, Sivins A, Kikuste I, Ancans G, Funka K, Lasina I, Tolmanis I, Vanags A, Leja M. CagA association with gastric cancer development risk. Helicobacter 2013; 18(Suppl. 1): 152-153 (P18.12).Type: abstractGastroPanel
2017Choi S.Can serum gastrin, pepsinogen I/II level and intragastric pH show existence of the atrophy in gastric neoplastic lesion before endoscopic submucosal dissection? Helicobacter 2011; 16(Suppl 1):91.Type: abstractGastroPanel
2017Kim SY, Kwon BS, Jung SW, Park JJ, Lee SW, Seol SY. Characteristics of atrophic gastritis in patients with erosive reflux disease (ERD) and non-erosive reflux disease. Helicobacter 2011; 16(Suppl 1):128 (P09.08).Type: abstractPepsinogens
2017Perets TT, Shporn E, Bareli Y, Kelner Y, Levy S, Aizic1 S, Pakanaev L, Niv Y, Dickman R. Clinical Accuracy and Usefulness of the Lactose Intolerance Quick Test for the Diagnosis of Lactose Malabsorption. Gastroenterology 2013;144 (5): S-473 (Su1774). DDW 2013 poster abstract; Su1774 (A-786).Type: abstractLactose Intolerance
2017Guarneri G, Ferrara FR, Slongo T, Murer F, Marcello R, Groppo M, Dal Bo N, Loperfido S, Schiavinato A, Scarpignato C, Di Mario F.Clinical picture of dyspepsia, role of infection, lactose intolerance and yellow stomach. Helicobacter 2012: 17 (Suppl. 1); 119 (P6.15).Type: abstractLactose Intolerance
2017Di Mario F, Cerati E, Cavallaro L, Cavestro GM, Dal Bó N, Ribeiro L, Fontana F, Seghini P, Moussa AM, Pilotto A, Franze A. Clinical usefulness of GastroPanel (SPGI, SPGII, Gastrin-17, HP specific IgG) in the Assessment of HP Infection. Gastroenterol 2003; 124 (4)(Suppl 1): A-176 (S1223).Type: abstractGastroPanel
2017Sishkova E, Lobach S, Nazarov V, Apechere B, Kuzmin-Krutetsky M, Paloheimo LI, Syrjänen K. COMPARISON OF BIOHIT HELICOBACTER PYLORI UFT300 QUICK TEST (LIQUID TEST) AND HELICOBACTER PYLORI QUICK TEST (GEL TEST) IN DETECTION OF HELICOBACTER PYLORI INFECTION IN A CLINICAL SETTING IN ST. PETERSBURG. Helicobacter 2014; 19 (Suppl. 1): 125 (P10.19).Type: abstractHelicobacter pylori UFT300
2017Francavilla R, Principi M, Ierardi E, Indreo F, Francavilla A.Control of Helicobacter pylori Infection by Dietary Supplementation With Lactobacillus Reuteri Strain Combination. Gastroenterology 2013;144 (5): S-54 (247). DDW 2013 Lecture presentaton abstract 247 (A-71).Type: abstractGastric disease
2017Koskinen SM, Putkonen P, Ruuska P, Jauhonen PV. Cost Evaluation of GastroPanel in Dyspepsia Patients over 50 Years of Age. Gut 2005; 54 (Suppl VII) :A91Type: abstractGastroPanel
2017Tamm A, Tein A, Peetsalu M, Sillakivi T, Kirsimägi Ü, Valle J, Peetsalu A.Dependence of serum antibodies (HP-Ab) against Helicobacter pylori colonsation in the gastric corpus and antrum mucosa. Helicobacter 2004; 9:510-511.Type: abstractGastroPanel
2017Di Mario F. Diagnostic accuracy of serum pepsinogens and gastrin to follow-up H.pylori infection. Helicobacter 2010;15(4):350Type: abstractGastroPanel
2017Ingegnoli A, Ferreri G, Del Rio P, Cerati E, Cavestro GM, Cavallaro LG, Leandro G, Basso D, Plebani M, Sianesi M, Di Mario F. Does Chronic Hypercalcemia Influence Serum Pepsinogen Levels? Gastroenterol 2003; 124 (4)(Suppl 1): A-446 (T903).Type: abstractPepsinogen
2017Tsukanov VV, Amelchugova OS, Vasyutin AV, Tretyakova OV, Rodina DV. Ethnic Differences of Uninvestigated Dyspepsia and Atrophic Gastritis Prevalence in Mongoloids and Europoids of Eastern Siberia Over 45 Years Old. Gastroenterology 2013;144 (5): S-511 (Su1926). DDW 2013 poster abstract; Su1926 (A-827).Type: abstractGastroPanel
2017Yılmaz Ö, Demiray E, Soytürk M, Perez Perez GI, Sağol Ö, Bekmen N, Şimşek I, Akpınar H. Evaluation of serum pepsinogen I and II levels, gastrin-17 and Helicobacter pylori antibodies in patients with dyspepsia. Helicobacter 2008; 13(5): 454 (P112).Type: scientific articleGastroPanel
2017Sudraba A, Funka K, Tolmanis I, Vanags A, Daugule I, Janciauskas D, Jonaitis L, Kupcinskas L, Ivanauskas A, Lin J, Chiu H, Leja M. Gastric biomarkers in H.pylori positive and negative patients. Helicobacter 2010; 15(4):353.Type: abstractGastroPanel
2017Ferrara F, Slongo S, Franceschet I, Rigoli R, Pascoli S, Dal Bò N, Caroli A, Marcello R, Schiavinato A, Scarpignato C, Di Mario Helicobacter pylori Infection in Primary Care: Clinical Usefulness of Gastropanel in Assessing Gastric Mucosal Damage. Helicobacter 2012: 17 (Suppl. 1); 93 (P2.34).Type: abstractGastroPanel
2017Tsukanov V, Amelchugova O, Vasyutin A, Tretyakova O. Helicobacter pylori is associated with uninvestigated dyspepsia and atrophic gastritis in the urban population of Siberia over 45 years old. Helicobacter 2012: 17 (Suppl. 1); 114 (P5.18).Type: abstractGastroPanel
2017Selgrad M, Kandulski A, Bornschein J, Roessner A, Malfertheiner P. Helicobacter pylori, decreased pepsinogen and atrophic gastritis are not associated with Barretts esophagus and erosive esophagitis. Helicobacter 2014;19 (Suppl.1):108 (P06.01).Type: abstractGastroPanel
2017Alonge Ivo Ebule.Application of GastroPanel serum markers (PG1, PGII, G-17, Hp-IgG) in the diagnosis of Helicobacter pylori infection-associated atrophic gastritis. M.Sc. Thesis. Faculty of Medicine and BioMedical Sciences, The Univeristy of Yaounde I, Cameroon, 2012Type: scientific articleGastoPanel
2017El-Zimaity H, Graham D Y, Campos A, Guerrero L, Chavez A, Cardenas V. Improved diagnoses of corpus gastric atrophy. Helicobacter 2005; 10 (5):500.Type: abstractGastroPanel
2017Myllyniemi M, Linnala A, Paloheimo LI, Hendolin P, Engstrand L, Perez Perez G, Sipponen P. Improved Specificity of Helicobacter pylori IgA/IgG ELISA over other H.pylori Tests. Helicobacter 2007; 12(4):447 (P116).Type: abstractHelicobacter
2017Sudraba A, Kikuste I, Daugule I, Funka K, Tolmanis I, Vanags A, Janciauskas D, Jonaitis L, Kupcinskas L, Ivanauskas A, Leja M.Improvement in pepsinogens long-term monitoring after eradication of Helicobacter pylori. Helicobacter 2011; 16(Suppl 1):125Type: abstractPepsinogens
2017Maejima R, Iijima K, Hendolin PH, Kaihovaara P, Paloheimo LI, Koike T, Shimosegawa T, Syrjänen KJ, Salaspuro M. Inactivation of Carcinogenic Acetaldehyde by Slowly L-Cysteine Releasing Capsule Formulation in Gastric Juice of PPI Treated Volunteers After Intra-Gastric Infusion of Ethanol. Gastroenterology 2014; 146(5): S-507 (Su1955). DDW 2014 Poster abstract Su1955Type: abstractAcetaldehyde Acetium
2017Song H, Held M, Sandin S, Rautelin H, Eliasson M, Söderberg S, Hallmans G, Engstrand L, Nyrén O, Ye W. Increase in the Prevalence of Atrophic Gastritis Among Adults Age 35 to 44 Years Old in Northern Sweden Between 1990 and 2009. Clinical Gastroenterology and Hepatology 2015;13:1592–1600.Type: scientific articlePepsinogens II
2017de Korwin JD, Prucha V, Lozniewski A, Vignaud JM, Conroy MC, Legoedec J. Non endoscopic diagnosis of atrophic gastritis using the GastroPanel/GastroSoft. Helicobacter 2004; 9: 561.Type: abstractGastroPanel
2017Sebastian S, McLouglin R, Hall W, Qasim A, O`Connor H, Buckley M, O`Morain CNon-Invasive Methods of Diagnosis of Gastric Intestinal Metaplasia – an Observational Case-Control Study. Gastroenterol 2003; 124 (4)(Suppl 1): A-423 (M2142). Type: abstractGastroPanel
2017Nurgalieva ZZ, Graham D Y, El-Zimaity H, Campos A, Guerrero L, Chavez A, Opekun AR, Cardenas V. Non-invasive testing for gastric atrophy in North America.Helicobacter 2005; 10 (5):502.Type: abstractGastroPanel
2017Varbanova M, Wex T, Kuester D, Malfertheiner P.OLGA and OLGIM staging systems do not correspond in a prospective setting Helicobacter 2012: 17 (Suppl1); 113 (P5.17).Type: abstractGastric disease
2017Leja M, Ancans G, Lasina I, Liepniece-Karele I, Rudzite D, Sivins A, Skapars R, Purmalis K, Eglitis J, Daugule IOnly minority of gastric adenocarcinomas present with decreased pepsinogen levels. Helicobacter 2012; 17 (Suppl. 1): 76 (W5.6)Type: abstractGastroPanel
2017Di Mario F, Gatta L, Fognini F, Rugge M, Caleffi A, Lippi G, Perazzo P, Iori A, Lucarini PP, Lera M, Scarpignato C, Vaira D, Cavestro GM, Soriani P, Curlo M, Franzè A. Pepsinogen I, II, Ratio, and G-17 in Patients with Esophagitis and Patients with Extra-Esophageal Manifestations of GERD. Gastroenterology 2011; 140 (5): S-258 (Sa1224). Poster presentation Sa1224 at DDW 2011.Type: abstractGastroPanel
2017Leja M, Lapina S, Rudzite D, Daugule I, Liepniece-Karele I, Eglitis J, Purmalis K, Tolmanis I, Lejnieks A, Rumba-Rozenfelde I, Vikmanis U. Pepsinogen II as a marker for successful H.pylori eradication. Helicobacter 2012: 17 (Suppl. 1); 93-94 (P2.36).Type: abstractPepsinogen II
2017Dampe Z, Isajevs S, Santare D, Polaka I, Ancans G, Sivins A, Skapars R, Lasina I, Rudzite D, Vikmanis U, Boka V, Leja M. Pepsinogen levels in patients with gastric adenocarcinoma. Poster presentation P04.08 at European Helicobacter Study Group 2015 congress. Helicobacter 2015:20(Suppl. 1); 106.Type: abstractGastric disease
2017Krike P, Polaka I. Santare D, Isajevs S, Liepniece-Karele I, Savvidou E, Janciauskas D, Tolmanis I, Kikuste I, Vanags A, Leja MPepsinogens and gastrin-17 in corpus–restricted gastritis. Poster presentation P01.03 at European Helicobacter Study Group 2015 congress. Helicobacter 2015:20(Suppl. 1); 86.Type: abstractGastroPanel
2017Sudraba A, Chui HM, Funka K, Engstrand L, Eriksson L, Janciauskas D, Jonaitis L, Kiudelis G, Kupcinskas L, Lin JT, Rudzite D, Leja M. Performance of routine H.pylori tests in patients with and without gastric mucosal atrophy in the corpus. Helicobacter 2008;13(5): 454 (P111Type: abstractGastroPanel
2017Sipponen P, Mäki T, Ranta P, Linnala A, Kääriäinen I, Helske T, Suovaniemi O, Härkönen M. Application of blood levels of gastrin-17, pepsinogen I and H.pylori antibody for nonendoscopic diagnosis of atrophic gastritis. Presented at the Digestive Disease Week, USA, May 20-23, 2001.Type: abstractGastroPanel
2017Massella A, Baldassarre G, Franceschi M, Panozzo MP, Tomba F, Sella D, Ferronato A, Antico A, Goni E, Scarpignato C, Di Mario F. ARE GENERIC PPIS LESS EFFECTIVE ANTISECRETORY DRUGS THAN BRANDED FORMULATIONS? A STUDY IN DYSPETIC PATIENTS WITH THE USE OF NON INVASIVE MARKERS OF GASTRIC FUNCTION. UEGW 2015 Poster presentation P1727.Type: abstractGastroPanel
2017Salaspuro M, Härkönen M, Marvola M, Peetsalu A, Sarna S, Sipponen P, Suovaniemi O, Syrjänen K, Syrjänen S, Wikström M. Asetaldehydi on vaiettu karsinogeeni. Suomen Lääkärilehti 2015; 33(70):1978-1979.Type: scientific articleAcetaldehyde
2010Reijo IkävalkoAsetaldehydi vaanii kaikkialla. Onko sinulla hapoton maha? Viva 08-2010 Viva 2010; 46;14-15.Type: articleAcetaldehyde
2017Perez-Perez GI, Olivares AZ, Sack R, Hasan K, Saker S, Bardham P, Blaser MJ. Assessment of Acquisition of Helicobacter pylori in Bangladeshi Children by Serologic Methods. Helicobacter 2003; Vol 8(4): 386 (A06.02).Type: abstractGastric disease
2017Cavallaro L, Moussa AM, Merli R, Bertolini S, Iori V, Cavestro GM, Caruana P, Dal Bó N, Aragona G, Fanigliulo L, Comoerato G, Franzé A, Francesco Di Mario. Assessment of H.pylori-related chronic gastritis by means of serum pepsinogens and oral sucrose test. Presentation at the 5th European Bridging Meeting in Gastroenterology, Bratislava, Slovak Republic, Nov 28-29, 2003Type: abstractGastroPanel
2017Wikström M. Assessment of Stomach Health by ‘Chemical Gastroscopy’. Eu Gastroenterology Rev 2012:7-12.Type: scientific articleGastroPanel
2017, Pawlowska A, Olszowiec K, Paradowski M. Assessment of the clinical feasibility of the new-generation immunoenzymatic quantitative ELISA assay for diagnosing Helicobacter pylori infections. Diagn Lab 2008;44:305-315.Type: scientific articleGastroPanel
2017Reshetnikov OV, Kurilovich S, Molchanova A.Association of H.pylori with pepsinogen II level. Helicobacter 2010; 15(4):371.Type: abstractGastroPanel
2017Aine R, Kahar E, Aitokari K, Salminen J, Eklund C, Paloheimo L, Peetsalu A, Syrjänen K. Atrophic gastritis (AG) and its clinical sequels among elderly people in Finland and Estonia. A comparative study using GastroPanel® and B12-vitamin testing in FOUR assisted-housing facilities. Helicobacter. Helicobacter 2016; 21(Suppl 1): 95 (P01.08).Type: abstractGastroPanel
2017Venerito M, Frauenschlaeger K, Di Mario F, Malfertheiner P. Autoimmune gastritis in subjects with autoimmune thyroid disease. Poster presentation at DDW 2015: Su1974.Type: abstractGastroPanel
1994Suovaniemi OAutomated instrumentation for clinical and research laboratoriesType: articleCompany
2017Silasvuo MBiohit Oyj vie suomalaista huippuosaamista maailmalle. Yksityislääkäri 2008; 1:99-101Type: articleCompany
2017Drygina LB, Poiarkova NA, Sablin OA.Clinical and laboratory evaluation of efficiency of Helicobacter pylori eradication. Eksp Klin Gastroenterol. 2010;(2):27-31. [Article in Russian]Type: scientific articleGastroPanel
2017dé Angelis G, Moussa AM, Fornaroli F, Caruana P, Magiteri B, Merli R, Altavilla N, Cavallaro LG, Cavestro GM, Di Mario F. Clinical Usefulness of GastroPanel (sPGI, sPGII, Gastrin, H.pylori specific lgG) in Assessment of H.pylori Infection in Children. Helicobacter 2003; Vol 8(4): 457 (A15.15).Type: abstractGastroPanel
2017Skrebinska S, Santare D, Isajevs S, Liepniece-Karele I, Rudzite D, Kikuste I, Vanags A, Tolmanis I, Atstupens J, Murillo R, Park JY, Herrero R, Daugule I, Leja MComparative evaluation of two serological tests for detection of H. pylori infection in Latvian population. Helicobacter 2016;21(Suppl 1):97 (P01.12).Type: abstractHelicobacter
2017Mooney PD, Wong SH, Kurien M, Burden M, Sanders DS. Comparison of three commercially available point of care tests for celiac disease. Poster presentation at DDW 2015: Sa1307.Type: abstractCeliac disease
2017Fang JY, Liu WZ, Shi Y, Ge ZZ, Xiao SD. Concensus on chronic gastritis in China – Second National Consensus Meeting on Chronic Gastritis (14 – 16 September 2006 Shanghai, China). J Dig Dis 2007; 8:107-119.Type: scientific articleGastric disease
2017Robles JC, Robles MC, Parrales GJ, Armijos LR, Suppo RJ, Landivar FB. Correlacion de los analisis sericos del pepsinogeno I, II, gastrina 17, anticuerpos anti-H.pylori, con las biopsias en pacientes dispepticos. Presentation at the XIII Ecuadorian Congress of Gastroenterology, Aug 2004Type: abstractGastroPanel
2017Daugule I, Sudraba A, Funka K, Tolmanis I, Vanags A, Janciauskas D, Jonaitis L, Kupcinskas L, Ivanauskas A, Lin J-T, Chiu H-M, Leja M. Correlation between the OLGA Gastritis stages and biomarkers for gastric mucosal atrophy. UEGW 2010. P0028.Type: abstractGastroPanel
2017Robles-Jara C, Robles-Medranda C, Parrales J, Armijos R, Suppo J, Landivar BCorrelation of Levels of Pepsinogen I and II, Gastrin-17, and H. pylori with the endoscopic biopsies of dyspeptic patients. Presentation at the World Congress of Gastroenterology September 12-14 2005, Montreal, CanadaType: abstractGastroPanel
2017Sebastian S, Hall W, Crotty P, O`Connor H, Buckley M, O`Morain C Jr.Detection of Helicobacter pylori Related Premalignant Lesions at Screening in First Degree Relatives of Gastric Cancer. Helicobacter 2003; Vol 8(4): 400 (A07.07).Type: abstractGastroPanel
2017Nicolini G, Zagari R, Pozzato P, Lunadei V, De Luca L, Antonini F, Ricciardiello L, Fossi S, Berretti D, Martuzzi C, Fuccio L, Maltoni S, Sipponen P, Bazzoli F, Roda EDiagnosis of atrophic gastritis based upon a combination of three non invasive tests: preliminary results of the Ioiano-monghidoro project. Italian Journal of International Gastroenterology and Hepatology 2001; A25 (abstract 76).Type: abstractGastroPanel
2017Nicolini G, Zagari R, Pozzato P, Lunadei V, De Luca L, Antonini F, Ricciardiello L, Fossi S, Berretti D, Martuzzi C, Fuccio L, Maltoni S, Sipponen P, Bazzoli F, Roda E.Diagnosis of Atrophic Gastritis Based upon a Combination of Three Non-invasive Tests: Preliminary Results of the Ioiano-Monghidoro Project. J Gastroenterol Hepatol 2002; 17 (Suppl): A264.Type: abstractGastroPanel
2017Zagari R, Nicolini G, Casaniva S, Fiocca R, Pozzato P, Lunedei V, Di Marco M, De Luca L, Ricciardello L, Martuzzi C, Fuccio L, Maltoni S, Grigioni W, Panuccio D, Sipponen P, Roda E, Bazzoli F. Diagnosis of Atrophic Gastritis in the General Population Based upon a Combination of Three Non-Invasive Tests. Gut 2002; Suppl II Vol 51: A39.Type: abstractGastroPanel
2017Vriezinga S, Van de Geest B, van Roessel K, Boers A, Putter H, Rings E, Wahab R, Mearin L. Accuracy of three commercially available point-of-care tests in monitoring celiac disease, Espghan 2016 lecture presentation. no internet connectionType: abstractCeliac disease
2015Mooney PD,  Wong SH,  Johnston AJ,  Kurien M,.Avgerinos A, Sanders DS. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy Clinical Gastroenterology and Hepatology 2015;13:1278–1284.Type: scientific articleCeliac disease
2017Redeén S, Petersson F, Borch K. Evaluation Blood Levels of Pepsinogens, Gastrin-17 and H. pylori Antibodies for Diagnosis of Gastritis in a General Population Sample. Helicobacter 2003; Vol 8(4): 399 (A07.03).Type: abstractGastroPanel
2017O’Connor JPA, Bailey Y, Gordon J, Shannon R, O’Morain CA, Ryan BM, Qasim A, O’Connor HJ, Breslin NP. Evaluation of a new rapid urease test for point-of-care diagnosis of Helicobacter pylori Infection. Irish Society of Gastroenterology Congress 2011. Poster presentationType: abstractHelicobacter pylori Quick Test
2017Di Mario F, Moussa AM, Caruana P, Iori V, Cavestro GM, Cavallaro LG, Dal Bò N, Cannizzaro R, Marcucci F, Muzzetto P, Franzè A. Evaluation of gastric function by means of gastropanel (SPGI, SPGII, G-17, IGG-HP) in first degree relatives of patients with gastric cancer. Dig Liver Dis 2003; 35 (suppl 4): S61.Type: abstractGastroPanel
2017Orzes E, Cannizzaro R, Maiero S, Tabuso M, Fornasarig M, de Re V, Steffan A, Cervo S, Canzonieri V. EVALUATION OF GASTROPANEL IN GASTRIC CANCER PATIENTS, FIRST-DEGREE RELATIVES AND AUTOIMMUNE CHRONIC ATROPHIC GASTRITIS (ACAG). UEG J 2013; A55 (OP178).Type: abstractGastroPanel
2017Portal-Celhay C, Perez-Perez GI, Olivares AZ, Francois F, Foo S, Bini E, Blaser MJ.Evaluation of Helicobacter pylori Status and Serum Pepsinogen Levels in Barrett’s Esophagus and Gastric Intestinal Metaplasia. Helicobacter 2003;Vol 8(4): 403 (A07.15).Type: abstractGastroPanel
2017Liatopoulou S, Moussa AM, Cavallaro LG, Merli R, Iori V, Aragona G, Cavestro GM, Nervi G, Dal Bo' N, Pilotto A, Franzé A, Di Mario F. Failure of Helicobacter pylori Eradication Therapy: A Comparison of Different Risk Factors (Laboratory vs. Environmental Items). Helicobacter 2003; Vol 8(4): 469 (A16.22).Type: abstractCeliac disease
2017Lomba-Viana R, Fonseca F, Vieira A, Bento MJ, Lomba-Viana H.Gastric cancer. The importance of the pepsinogen test. UEGW 2010. P1233.Type: abstractGastroPanel
2017Goni E, Ricco M, Franceschi M, Baldassarre G, Panozzo MP, Antico A, De Bastiani R, Scarpignato C, Di Mario F. Gastrin 17 as non-invasive marker of Reflux disease. Poster Presentation at DDW 2015: Mo1135.Type: abstractGastroPanel
2017Rehfeld JF, Bardram L, Goetze JP, Hilsted L. Gastrin som markØr for gastrinomer: et lærestykke om immunanalyse-kits. Klinisk Biokemi I Norden. 2011;3:20-23Type: scientific articleGastrin
2017Di Mario F, Bertolini S, Cavallaro L.G, Stefani N, Nervi G, Pilotto A. Gastrin-17 (G-17) and Serum Pepsinogen I (sPGI) for Evaluation of Patients With Gastroesophageal Reflux Disease (GERD) Compared To Dyspeptics or Ulcerous. Gastroenterology 2005; 128 (4) (Suppl 2).Type: abstractGastroPanel
2017Cavallaro LG, Maini A, Nouvenne A, Merli R, Morana E, Guida L, Iori V, Cavestro GM, Gnocchi A, Franzè A, Di Mario F. GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) INDEPENDENTLY OF H. PYLORI STATUS. Gut 2006; Vol 55 (suppl V): A267Type: abstractGastroPanel
2017Redeen S, Petersson F, Kechagias S, Rehfeld J, Borch KGastroduodenal Changes Two Years After Eradication of Helicobacter pylori in a Population-Based Cohort. Gastroenterol Res. 2015;8(2):171-177.Type: scientific articleGastroPanel
2017Guariso G, Basso D, Fasolo M, Conte S, Tasinato A, Navaglia F, Fogar P, Zambon CF, Grego E, Schiavon S, Plebani M. GastroPanelGastroPanel: A Useful Screening Test in Pediatric Populations. Helicobacter 2006;11(4): 374 (09.07).Type: abstractGastroPanel
2017Charlier-Bret N, Boucher B, Ly TD, Soussy CJ, Zerbib F, Duran Cordobes M, Fromage M, Poisson F, Vaugelade C, Courillon Mallet A, De Korwin JD, Fauchère JL, Mégraud F, Raumind J, Delchier JC (AFSSAPS)HELICOBACTER PYLORI IGG – ÉVALUATION COMPARATIVE DE 29 DISPOSITIFS MÉDICAUX DE DIAGNOSTIC IN VITRO (DMDIV) DISPONIBLES EN FRANCE EN 2008. RICAI 2009, Paris, France. http://www.ricai.fr/archives/2009/ 25/StreptocoquesType: abstractHelicobacter
2017Sipponen P, Linnala A, Paloheimo Li, Härkönen M, Suovaniemi O. Helicobacter pylori infection and related risks and diseases – towards optimal diagnostics and evidence based medicine. Presentation at the Gastro 2002, St. Petersburg, Russia, 17-20 Sept 2002.Type: abstractGastroPanel
2017Kurlen M, Evans KE, Irvine AJ, Hale MF, Chalkiadakis I. How does a blood transglutaminase-based rapid test compare to conventional serological markers to detect coeliac disease? Gut 2012; 61(Suppl. 3): A334Type: abstractCeliac disease
2017Nitti G. Ideato in Finlandia un nuovo test per il mal di stomaco. Virtual Tour Service Attualita 22.12.2004.Type: scientific articleGastroPanel
2017de Bastiani R, Bacchin P, Bortot M, Polizzi G, Benedetto E, Sanna G, Nebiacolombo C, Cuffari A, Pirrotta E, Marchionne M, Ciumeo F, di Mario F. Il GastroPanel: un test di diagnoistica prezioso e poco conosciuto in medicina generale. il Caduseo 2014; 16(2): 5 (Italian).Type: scientific articleGastroPanel
2017Di Mario F, Seghini P, Moussa AM, Iori V, Aragona G, Cavestro GM, Dal Bo N, Maino M, Mantovani N, Ingegnoli A, Pilotto A, Franze A. Influence of Different Epidemiological, Pharmacological and Biological Factors of Serum Pepsinogen Levels. Gut 2002; Suppl II Vol 51: A29Type: abstractGastroPanel
2017Sipponen P. Kirjeitä ja mielipiteitä. PPI-lääkitys, hapoton maha ja luunmurtumavaara. Duodecim 2011; 127:126.Type: articleGastroPanel
2017Vauhkonen M, Sipponen P, Helske T, Kääriäinen I, Härkönen M. Low serum gastrin-17 predicts long-segment Barrett’s esophagus. Presentation at the Finnish Medical Exhibition (Lääkäripäivät 2004), Helsinki, Finland, Jan 4-8 2004Type: abstractGastroPanel
2017Eronen A. Mahalaukun kunto selville yksikertaisella tekstillä. Ideapark Uutiset 22.4.2009: 6.Type: articleGastroPanel
2017Aitio A. Mittasuhteita asetaldehydin karsinogeenisyydelle. Suomen Lääkärilehti 2015;30 (70): 2394-2395.Type: scientific articleAcetaldehyde
2011Leja M, Upmace I, Park JY, Plummer M, Herrero R. MULTICENTRIC RANDOMIZED STUDY OF H.PYLORI ERADICATION AND PEPSINOGEN TESTING FOR PREVENTION OF GASTRIC CANCER MORTALITY (GISTAR). THE STUDY DESIGN. UEG J 2013; 1 (Suppl 1):A4 (OP016).Type: abstractGastroPanel
2017Shakeri R, Malekzadeh R , Nasrollahzadeh D, Islami F, Sotoudeh M, Michel A, Murphy G, Etemadi A, Poustchi H, Waterboer T, Pawlita M, Brennan PJ, Boffetta P , Dawsey SM, Kamangar F, Abnet CC. Multiplex Helicobacter pylori Serology and risk of Gastric Cardia and Non-cardia Adenocarcinomas. Poster presentation at DDW 2015: Sa1948.Type: abstractHelicobacter
2017Mayev IV, Melnikova YV, Kryukova TV, Kashin SV, Nadezhin ASNew methods of serological and endoscopic diagnostics of chronic atrophic gastritis and early stomach cancer. Clinical Perspectives of Gastroenterology and Hepatology 2009; 6:30-34. [Article in Russian]Type: abstractGastroPanel
2017Korwin JD, Prucha V, Vignaud JMM, Conroy MC, Lozniewski A. NON NON ENDOSCOPIC DIAGNOSIS OF ATROPHIC GASTRITIS: EVALUATION OF THE GASTROPANEL/GASTROSOFT. Gut 2007; 56(Suppl 3):A96Type: abstractGastroPanel
2017Sipponen P, Suovaniemi O, Härkönen M. Non-endoscopic diagnosis of atrophic gastritis by blood test. Presentation at the International Congress of the Middle-East and African Gastroenterologists Association in Amman, Jordan, 28-31 Aug 2002.Type: abstractGastroPanel
2017Sipponen P, Linnala A, Suovaniemi O, Härkönen M. Non-endoscopic diagnosis of atrophic gastritis by using blood test. Presentation at the Fourth Western Pacific Helicobacter Congress in Perth, Western Australia, March 2002.Type: abstractGastroPanel
2017Grattagliano I, Portincasa P. Non-invasive prediction of chronic atrophic gastritis by Gastropanel®. Poster presentation at ESCI 2015. 49th Annual Scientific Meeting of the European Society for Clinical Investigation. Cluj-Napoca, Romania – 27-30 May 2015.Type: abstractGastroPanel
2017Salaspuro M, Sipponen P. Ohjeet dyspepsiapotilaan tutkimuksesta päivitettävä. Duodecim 2011; 127:576-7Type: articleGastroPanel
2017Baldassarre G, MP Panozzo MP, Santacatterina M, Tomba F, Sella D, Ferronato A, Antico A, Di Mario F, Franceschi M. Prevalence of H. pylori infection, chronic atrophic gastritis and reflux disease in a primary care population of North Italy with serum biomarker panel (GastroPanel®). Poster presentation at Fismad congress 2017.Type: abstractGastroPanel
2017Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, Rumba-Rozenfelde I, Liepniece-Karele I, Pahomova J, Purmalis K, Eglitis J, Pirags V, Dzerve V. Prevalence of H.pylori infection and atrophic gastritis in Latvia. Helicobacter 2012: 17 (Suppl. 1); 86 (P2.03).Type: abstractGastric disease
2017Zanussi S, Casarotto M, Basaglia G, Tedeschi R, Giacomini S, Canzonieri V, De Re V, Maiero S, Cannizzaro R, De Paoli P. Prevalence of Helicobacter pylori infection and its genetic heterogeneity in Autoimmune Atrophic Chronic Gastritis patients. Helicobacter 2013; 18(Suppl. 1): 112-113 (P07.08).Type: abstractGastroPanel
2017Cavallaro LG, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavestro GM, Iori V, Merli R, Franzè A, Rugge M, DiMario F. Recovery of gastric function after H. Pylori eradication in subjects with body atrophic gastritis: A prospective four years study. Helicobacter 2004; 9 (5): 527 (A06.04).Type: abstractGastroPanel
2017Moussa AM, Dal Bò N, Caruana P, Cavallaro LG, Aragona G, Liatopoulou S, Cavestro GM, Iori V, Merli R, Maini A, Gnocchi A, Pilotto A, Franzé A, Di Mario FRecovery of gastric function after H.pylori eradication in subjects with body atrophic gastritis: a prospective four years study. Presentation at the 5th European Bridging Meeting in Gastroenterology, Bratislava, Slovak Repuplic, Nov 28-29, 2003.Type: abstractGastric disease
2017Di Mario F, Rugge M, Ferrara F, Dal Bò N, Slongo T, Marcello R, Heras Salvat H, Guarnieri G, Caroli A, Rigoli R, Dei Tos AP, Scarpignato CRecovery of Gastric Function After Helicobacter pylori Eradication and Acetium Administration: a 6 Years Study in Atrophic Gastritis Subjects. Gastroenterology 2013;144 (5): S-352-353 (Sa 1988). DDW 2013 poster abstract; Sa1988 (A-561).Type: abstractGastroPanel Acetium
2017Di Mario F, Rugge M, Ferrara F, Slongo T, Dal Bo' N, Guarnieri G, Marcello R, Heras Salvat H, Rigoli R, Dei Tos A, C. Scarpignato.Recovery of gastric function after Helicobacter pylori eradication and Acetium administration: a 6 years study in atrophic gastritis subjects. Helicobacter 2013; 18 (Suppl. 1):109 (P06.03).Type: abstractGastroPanel Acetium
2017Di Mario F, Rugge M, Ferrara F, Slongo T, Dal Bo´ N, Guarnieri G, Marcello R, Caroli A, Heras Salvat H, Rigoli R, Dei Tos AP, Scarpignato C. RECOVERY OF GASTRIC FUNCTION AFTER HELICOBACTER PYLORI ERADICATION AND ACETIUM ADMINISTRATION: A 6 YEARS STUDY IN ATROPHIC GASTRITIS SUBJECTS. UEG J 2013;1 (Suppl 1): A421 (P1069).Type: abstractGastroPanel Acetium
2005Di Mario F, Moussa AM, Dal Bo N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Merli R, Franzé A, Rugge M . Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study. J Gastroenterol Hepatol 2005: 20;1661-1666.Type: scientific articleGastroPanel
2017Moussa AM, Iori V, Aragona G, Seghini P, Cerati E, Campi L, Cavestro GM, Comparato G, Leandro G, Battaglia G, Dal Bo N, Franze A, DiMario F. Relationship between Direst and Indirect Methods for Diagnosis of H. pylori Infection. Gut 2002; Suppl II Vol 5: A110Type: abstractGastroPanel
2017Venerito M, Kohrs S, Wex T, Mönkemüller K, Schubert D, Adolf D, Malfertheiner P. Relationship between Helicobacter pylori infection. Gastric atrophy and the risk of oesophageal squamous cell carcinoma in Germany. Gut 2009; 58 (Suppl II);A13Type: abstractGastroPanel
2017Slongo T, Ferrara F, Dal Bò N, Loperfido S, Heras Salvat H, Furlanetto A, Dei Tos A, Scarpignato C, Rugge M, Di Mario FRelationship between OLGA and Gastropanel in Patients with Upper Gastrointestinal Disorders. Helicobacter 2012: 17 (Suppl. 1); 115 (P5.23).Type: abstractGastroPanel
2017Haj-sheykholeslami A, Bashiri MJ, Massarrat S. Screening of gastric cancer by serum Pepsinogens and Gastrin17. Helicobacter 2008; 13(5): 475 (P163).Type: abstractGastroPanel
2017Raziq AH, Al-Abbudi FA, Razak AH. Screening of H. pylori Positive Patients for the Potential Presence of Atrophic Gastritis through Studying the Gastric Panel and Anti- Helicobacter Antibodies. IJCEBS 2015; 3 (1) ISSN 2320–4087 (Online).Type: scientific articleGastroPanel
2017Ruchkina JH, Lychkova AE, Fadeev NA, Shcherbakov PL, Knyazev A. Secondary lactase deficiency and the influence of microflora in the small intestine to the electromotor intestinal smooth muscle activity. Doctor.Ru. Gastroenerology 2015; 2(103): 56-60. (in Russian).Type: scientific articleLactose Intolerance
2017Tamm A, Tein A, Peetsalu M, Soplepman J, Sillakivi T, Laja E, Mesila I, Valle J, Peetsalu A. Seerumi H.pylori IgG antikehade (S-Hp AK) sõltuvus mao korpuse ja antrumi limaskesta koloniseeritusest H.pyloriga. Research Conference in Medicine at the Medical Faculty of Tartu University 2003.Type: abstractGastroPanel
2017Oksanen A, Paloheimo L, Rautelin H. Selecting patients for re-gastroscopy. Helicobacter 2011; 16(Suppl 1):113.Type: abstractGastroPanel
2017Chukov SZ, Pasechnikov VD, Kotelevets SM, Mernova VP, Polyakova MB, Mostovov AN. Sensitivity, specificity and the prognostic value of non-invasive detection of stomach mucosal atrophy. Gut 2004; 53(Suppl VI): A124 (MON-G-257). Type: abstractGastroPanel
2017Pasechnikov VD, Chukov SZ, Kotelevets SM, Polyakova MB, Chabannaya TASerological and Morphological Correlations in H.pylori-associated Gastric Mucosal Pprecancerous Changes. Gut 2005; 54 (Suppl VII) :A130Type: abstractGastroPanel
2017Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterology 2012, 12:10_online.Type: abstractGastric disease
2017Franceschi M , Antico A , Panozzo MP, Tomba F, Ferronato A, Sella D, Baldassarre G, Di Mario F. Serological diagnosis of upper GI diseases in primary care settings. Poster presentation at DDW 2015: Sa1749.Type: abstractGastroPanel
2017Kurilovich S, Reshetnikov O, Voevoda M, Simonova G, Openko T, Ragino Y, Krotov S, Krotova V. Serological markers of atrophic gastritis may determine the risk of gastric cancer in a population-based study. Helicobacter 2010;15(4):324Type: abstractGastroPanel
2017Vohlonen I, Syrjänen K, Karhu J. Serum Biomarker-Based Screening of the Risk Groups of Stomach Cancer. Preliminary results of a feasibility study in Finland. Güncel Gastroenteroloji 2013; 17(3):171-176.Type: scientific articleGastroPanel
2017Vohlonen I, Syrjänen K, Karhu J. Serum biomarker-based screening of the risk groups of stomach cancer. Preliminary results of a feasibility study in Finland. Mide kanseri risk gruplarının “serum biomarker” temelli taraması. Akademik Gastroenteroloji Dergisi, 2013; 12 (2): 47-51Type: scientific articleGastroPanel
2017Hajsheykholeslami A, Rakhshani N, Amirzargar A, Zendehdel N, Shahidi SM, Nikbin B, Saeidi S, Massarrat S. SERUM BIOMARKERS PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17 IN FIRST DEGREE RELATIVES OF GASTRIC CANCER PATIENTS: A COMPARATIVE STUDY WITH TOPOGRAPHY AND GRADE OF GASTRITIS. Gut 2007; 56(Suppl 3):A93.Type: abstractGastroPanel
2017Haj-sheykholeslami A, Rakhshani N, Amirzargar A, Zendehdel N, Shahidi S, Nikbin B, Khosravi F, Massarat S. Serum Biomarkers Pepsinogen I, Pepsinogen II and Gastrin-17 in First Degree Relatives of Gastric Cancer Patients: A Comparative Study with Topography and Grade of Gastritis. Helicobacter 2007; 12(4):465-466 (P167).Type: abstractGastroPanel
2017Sipponen P, Vauhkonen M, Helske T, Kääriäinen I, Härkönen M. Serum fasting level of gastrin-17 is low in patients with long-segment Barrett’s esophagus. Gastroenterology 2004; Vol 126 (4)(Suppl 2):A-177 (S1234Type: abstractGastroPanel
2017Hosseini M, Amoueian S, Attaranzadeh A, Montazer M, Soltani G, Asadollahi K, Abangah GSerum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran. J Res Med Sci. 2013 March; 18(3): 225–229.Type: scientific articleGastroPanel
2017Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, Willich SN, Stolte M, Hocker M, Jaspersen D, Lind T, Malfertheiner P. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther 2008; 28(4):491-6.Type: scientific articleGastroPanel
2017Sudraba A, Kikuste I, Daugule I, Funka K, Tolmanis I, Vanags A, Janciauskas D, Jonaitis L, Kupcinskas L, Ivanauskas A, Leja MSERUM PEPSINOGEN CONCENTRATIONS DINAMIC AFTER H. PYLORI ERADICATION IN LONG TERM FOLLOW UP. Gut 2011; Vol 60 (suppl 3): A384.Type: abstractPepsinogens
2017Mahachai V, Thongbai T, Ratanachu-ek T, Khuhaprema T, Vilaichone R. Serum Pepsinogen I and II in Dyspeptic Patients in Thailand – Is it Useful? Helicobacter 2010; 15(4):323.Type: abstractGastroPanel
2017Mantovani N, Ingegnoli AV, MAino M, Altavilla N, Seghini P, Cerati E, Carloni C, Cavallaro L, CAvestro MG, Leandro G, Pilotto A, Dal Bo N, Di Mario F. Serum Pepsinogen I and sucrose test after administration of non-steroideal anti.inflammatory drugs. Gut 2002: 51 (Suppl II) A313 (WED-G-555).Type: abstractGastroPanel
2017Ranta P, Helske T, Kääriäinen I, Mäki T, Saarinen P, Kekäläinen L, Suovaniemi O, Härkönen M, Sipponen P. Serum pepsinogen I test reveals cases of vitamin B12 defieciency without anemia in patients with gastric corpus atrophy. Clin Chem Lab Med 2001; 39 (Suppl.). Presented at Euromedlab 2001, Prague, May 26-31Type: abstractGastroPanel
2017Cavallaro L, Stefani N, Merli R, Morana E, Maino M, Iori V, Cavestro G, Bertelè A, Franzè A, Di Mario F.Serum Pepsinogen II & Gastrin-17 as Markers of NSAIDs-gastropathy independently of H. pylori infection. Helicobacter 2005; 10 (5):540.Type: abstractGastroPanel
2017Cavallaro LG, Stefani N, Merli R, Liatopoulou S, Maini A, Maino M, Iori V, Cavestro GM, Gnocchi A, Muzzetto P, Franzè A, Di Mario FSerum Pepsinogen II and Gastrin-17 as Markers of NSAIDs Gastropathy. Gut 2005; 54 (Suppl VII) :A117Type: abstractGastroPanel
2017Ingegnoli A, Moussa AM, Altavilla N, Seghini P, Cerati E, Mantovani N, Aragona G, Caruana P, Cavestro GM, Leandro G, Dal Bo N, Di Mario F. Serum Pepsinogens and Sucrose Test in Helicobacter pylori Related Gastritis. Gut 2002; Suppl II Vol 51: A29Type: abstractGastroPanel
2017Venerito M, Schinkel S, Gatta L, Peitz U, Wex T, Di Mario M, Malfertheiner P. Serum pepsinogens and topography of chronic atrophic gastritis in a population sample referred for endoscopy. UEGW 2010. P0864Type: abstractGastroPanel
2017Venerito M, Schinkel S, Gatta L, Peitz U, Wex T, Di Mario F, Malfertheiner P. Serum pepsinogens and topography of chronic atrophic gastritis in a population sample referred for endoscopy. UEGW 2010. P0864.Type: abstractGastroPanel
2017Venerito M, Radünz M, Reschke K, Mertens PR, Di Mario F, Malfertheiner P.Serum Pepsinogens for Detection of Fundic Gastric Atrophy in Subjects With Autoimmune Thyroid Disease. Gastroenterology 2014; 146, (5): S-314 (Sa1860).DDW 2014 poster abstract Sa1860.Type: abstractGastric disease
2017Venerito M, Radünz M, Reschke K, Mertens P, Di Mario F, Malfertheiner P. Serum pepsinogens for detection of fundic gastric atrophy in subjects with autoimmune thyroid disease. Helicobacter 2014; 19 (Suppl. 19): 84 (W4.6).Type: abstractGastroPanel
2017Cavallaro LG, Morana E, Guida L, Liatopoulou S, Moussa AM, Cavestro GM, Franze A, Di Mario F. Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relatioship with Density of the Bacterium, Inflammation, and Atrophy. Helicobacter 2006;11(4): 352 (05.21).Type: abstractGastroPanel
2017Nurgalieva ZZ, Opekun AR, Conner MC, Graham DY. Serum pepsinogens in the diagnosis of acute Helicobacter pylori infection. Helicobacter 2005; 10 (5):519.Type: abstractGastroPanel
2017Suovaniemi O.State of art GastroPanel and Acetium Innovations for the unmet need. Terveyspalvelut 2011; 2-3 (erillispainos): 2-12.Type: abstractGastroPanel Acetium
2011Suovaniemi OsmoState of the art GastroPanel and Acetium Innovations for the unmet needType: scientific articleGastroPanel Acetium
2017Altavilla N, Moussa AM, Seghini P, Cerati E, Cavallaro LG, Cavestro GM, Dal Bo N, Pilotto A, Cannizzarro R, Maino M, Leandro G, Franze A, Di Mario F. Sucrose Test and Serum Pepsinogens as Markers of Inflammation and Damage in Helicobacter pylori -Related Gastritis. Gut 2002;Suppl II Vol 51: A30.Type: abstractGastroPanel
2017Reshetnikov V, Kurilovich SA, Tatarinova OV, Abramova KP. The incidence of gastric cancer biomarkers in residents of circumpolar community. Helicobacter 2012: 17 (Suppl1); 113 (P5.13).Type: abstractGastroPanel
2017Ghanghro I, Basu S, Vidyarthi M, McTaggert C, Hollanders D. The Incidence of Lactose Deficiency in an endoscopically and histologically normal group of white Caucasians. Gastroenterology Today 2009; 19(3):76-78Type: abstractLactose Intolerance
2017Sudraba A, Rudzite D, Daugule I, Tolmanis I, Engstrand L, Janciauskas D, Jonaitis L, Kupcinskas L, Ivanauskas A, Lin J, Chiu H, Leja MThe performance of routine H.pylori tests in patients with atrophic gastritis. Helicobacter 2010; 15(4):359.Type: abstractGastric disease
2017Paik CN, Chung IS, Park JM, Cho YK, Lee IS, Kim SW, Choi MG. THE RELATION BETWEEN PEPSINOGEN I/II RATIO AND AGE OR UPPER GASTROINTESTINAL DISEASES IN HELICOBACTER PYLORI-POSITIVE AND –NEGATIVE SUBJECTS. Gut 2007; 56 (Suppl 3);A89.Type: abstractGastroPanel
2017George DA, Hui LL, Rattehalli D, Lovatt T, Perry I, Green M, Robinson K, Brookes MJ, Walters JRF. The role of near patient coeliac serology testing in the follow-up of patients with coeliac disease. Gut 2011; 60:A17.Type: abstractCeliac disease
2017Cesari S, Goni E, Street M, Bonaguri C, Caleffi A, Lippi G, Bernasconi S, Di Mario F. Thyrogastric autautoimmunity in children. Helicobacter 2014;19 (Suppl.1):118 (P09.03).Type: abstractGastroPanel
2017Telaranta I. Tähystystä ei aina tarvita. Eeva, Terveyspalsta 2007; 5:83Type: abstractGastroPanel
2017Di Mario F. Usefulness of GastroPanel for screening of atrophic gastritis in patients with autoimmune thyroid disease. Helicobacter 2010; 15(4):385Type: abstractGastroPanel
2017Di Mario F.Usefulness of GastroPanel for screening of atrophic gastritis in patients with autoimmune thyroid disease. UEGW 2010. P0030.Type: abstractGastroPanel
2017Moussa AM, Cavallaro LG, Caruana P, Bosi S, Cavestro GM, Campi L, Ingegnoli A, Sereni G, Corrente V, Franze A, Di Mario F. Usefulness of GastroPanel in Different Topography of H. pylori Related Chronic Gastritis. Helicobacter 2003; Vol 8(4): 383 (A05.03).Type: abstractGastroPanel
2017Di Mario F, Di Mario F, Rugge M, Cavestro GM, Scarpignato C, Perazzo P, Crafa P, Caruana P, Gatta L, Valenza D, Franzè A.Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis. Gastroenterology 2011; 140 (5): S-318 (Sa1742). Poster presentation Sa1742 at DDW 2011.Type: abstractGastroPanel
2017Di Mario F.Utility of serum pepsinogens to identify chronic atrophic gastritis. Helicobacter 2010; 15(4):362-363.Type: abstractGastroPanel
2017Valenza D, Di Mario F, Moschni I, Franzé A, Gatta L, Vaira D, Cavestro GM, Scarpignato C.Utility of serum pepsinogens to identify chronic atrophic gastritis. UEGW 2010. P1124Type: abstractGastroPanel
2017Laheij RJF, Oijen MGH, Paloheimo LI, Jansen JBMJ.Vitamin B12 Deficiency and Gastric Functioning in Patients with Cardiovascular Disease. Gut 2002; Suppl II Vol 51: A152.Type: abstractGastroPanel
2017Syrjänen KYksinkertainen testi paljastaa onko mahalaukku terve. BestPractice 2013; 4:26-33.Type: scientific articleGastroPanel
2017Di Mario F, Cavallaro L.G, Liatopoulou S, Moussa A, Maini A, Bertolini S, Merli R, Dal Bò N, Iori V, Stefani N, Cavestro G.M, Marcucci F, Rugge M, Franzè A. Accurancy of "serological gastric biopsy" in a cohort of dyspeptic patients. Gastroenterology 2005; 128 (4), Suppl 2).Type: abstractGastroPanel
2017Pimanov SI, Makarenka AV Bacterial load after Helicobacter pylori eradication predicts the changes of gastric antral mucosa, serum gastrin-17, pepsinogen-I and pepsinogen-II levels. Helicobacter 2005; 10 (5):502.Type: abstractGastroPanel
2017Charlier-Bret N, Boucher B, Ly TD, Soussy CJ, Zerbib F, Duran Cordobes M, Fromage M, Poisson F, Vaugelade C, Courillon Mallet A, De Korwin JD, Fauchère JL, Mégraud F, Raumind J, Delchier JC (AFSSAPS)HELICOBACTER PYLORI IGG – ÉVALUATION COMPARATIVE DE 29 DISPOSITIFS MÉDICAUX DE DIAGNOSTIC IN VITRO (DMDIV) DISPONIBLES EN FRANCE EN 2008. RICAI 2009, Paris, France. http://www.ricai.fr/archives/2009/ 25/StreptocoquesType: abstractHelicobacter
2017Ebule IA, Djune Fokou AK, Anago TC, Heugueu C, Tanni B, Paloheimo LComparison of rapid urease and histology tests for the diagnosis of Helicobacterpylori infection in Cameroon. Sch. J. App. Med. Sci., 2017; 5(4A):1240-1242.Type: abstractHelicobacter pylori Quick Test
2017Syrjänen K, Eronen K, Hendolin P, Paloheimo L, Eklund C, Bäckström A, Suovaniemi O. Low-Release L-Cysteine (Acetium®) Lozenge is an Effective New Method in Smoking Cessation. A randomised, double-blind, placebo-controlled intervention. AntiCancer Research 2017;37:3639-3648.Type: scientific articleAcetaldehyde
2017Sipponen P, Koskenpato J, Sotka M, Sandström R, Turunen M, Väänänen H, Tunturi-Hihnala H, Rasmussen M, Sande N, Suovaniemi O, Härkönen M. Value of the Test Panel Composing of Serum Assays of Pepsinogen I, Gastrin-17 and H. pylori Antibodies in Non-Endoscopic Diagnosis of Gastritis and Atrophic Gastritis. A Preliminary Prospective Study. Presentation at the World Congress of GastroenterologyType: abstractGastroPanel
2017Mahmood T.STUDY OF VARIATION BETWEEN THE ENDOSCOPIST, PATHOLOGIST AND THE BIOCHEMIST IN THE DIAGNOSIS OF CHRONIC FUNDAL ATROPHIC GASTRITIS: THERE IS NEED FOR DEFINITIVE GUIDELINES. Poster presentation at UEGW P0420. United European Gastroenterology Journal 2016; 4(Type: abstractGastroPanel
2012Kartal-Hodzic Alma. Formulation studies for eliminating saliva carcinogenic acetaldehyde with L-cysteine containing chewing gum. Ph.D. Dissertation, University of Helsinki, 2012Type: otherAcetaldehyde
2017Ebule IA, Djune Fokou AK, Sitedjeya Moko I L, Tanni B, Heugueu C, Longdoh AN, Noah Noah D, Okomo Assoumou MC, Paloheimo L, Njoya O, Syrjanen KPrevalence of H. pylori Infection and Atrophic Gastritis among dyspeptic subjects in Cameroon using a Panel of Serum Biomarkers (PGI, PGII, G-17, HpIgG). Sch. J. App. Med. Sci., 2017; 5(4A):1230-1239Type: scientific articleGastroPanel
2017Sipponen P, Suovaniemi O, Härkönen MThe Role of Pepsinogen Assays as Surrogate Markers of Gastritis Dynamics in Population Studies; in Hunt RH, Tytgat GNJ (eds): Helicobacter pylori – Basic Mechanisms to Clinical Cure 2002. Kluwer Academic Publishers and Axcan Pharma, 2003; 127-132.Type: otherPepsinogen
2017Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y.A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017;112(5):704-715.Type: scientific articleGastroPanel
2017Shan JH, Bai XJ, Han LL, Yuan Y, Sun XF Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population. Worls J Gastroenterol 2017; 23(32):5945-5953. doi: 10.3748/wjg.v23.i32.5945.Type: articleGastroPanel
2008Cavallaro L, Minelli R, Iori A, Merli R, Nouvenne A, Maini A. Bertelè A, Franzè A, Di Mario FUsefulness of “serological gastric biopsy” in patients affected by autoimmune thyroid disease (AITD). Gut 2007; 56(Suppl III):A237.Type: scientific articleGastroPanel
2017Di Mario F, Franze A, Cavallaro LG. Un Approccio Non Invasivo Alla Diagnosi Delle Malattie Dello Stomaco. One Global Medicine s.r.l. 2003; 1-48.Type: otherGastroPanel
2017Plebani M. Un Approccio Non Invasivo: Alla Diagnosi Delle Malattie Gastrointestinali. EDRA Medical Publishing and New Media 2002; 1-52.Type: otherGastroPanel
2017Kurilovich S, Belkovets A, Reshetnikov O, Openko T, Ragino Y. The First Steps in the Development of Gastric Cancer Riskometry: the Siberian Retrospective Case- Control Study. Novosibirsk State Medical University, Russian Federation. Gastroenterology 2014; 146(5):S- 337-338 (Sa1952a). DDW 2014 poster abstract Sa 1952Type: abstractGastroPanel
2017Tran Khanh Hoan.Study on Helicobacter pylori antibody, pepsinogens, gastrin-17 concentrations and their relationship with chronic gastritis. L’Hôpital Francais De Hanoi, Vietnam. 17.9.2008. Supervisors: Prof. Phung Dac Cam and Prof. Le Huy ChinhType: otherGastroPanel
2017Pyurveyeva KV, Lapina TL, Ivashkin VT, Kon'kov MYu, Sklyanskaya OA, Serova AG, Vasil'yeva NYu. Serum pepsinogen I, pepsinogen II and gastrin-17 in diagnostics of atrophic gastritis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2005; 3:48-51.Type: scientific articleGastroPanel
2017Subbotin AM. Opportunities of gastroscopy and diagnostic panel "GastroPanel" in diagnosis and treatment of precancer lesions of gastric mucous. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A126.Type: abstractGastroPanel
2017Di Mario F, Franze A, Cavallaro LG. Non-Invasive Diagnosis for Gastric Diseases. One Global Medicine s.r.l. 2004; 1-48.Type: otherGastroPanel
2017Hatim Al abbas Mostafa Sid Ahmed. Master of Sciences Thesis. Evaluation of a new ELISA panel for screening of atrophic gastritis, University of Khartoum. Institute of endemic diseases. May 2005Type: otherGastroPanel
2017Salaspuro M. Kirjeitä ja mielipiteitä: Ovatko »testaa ja hoida» -strategian haitat hyötyä suuremmat? Duodecim 2005; 121:852.Type: articleGastroPanel
2017Järvinen L, Sipponen P, Suovaniemi OJärvinen L, Sipponen P, Suovaniemi O. GastroPanel-diagnostiikkaa ja seulontaa. Yksityislääkäri 2005; 1:95-98.Type: scientific articleGastroPanel
2017Stotzka JGrowth phases and survival of high-sytem international new ventures originating from Finland. University of Vaasa. Faculty of Business studies. Department of Marketing. Vaasa, FinlandType: otherother
2017Di Mario F, Goni E.GastroPanel®. A NON-INVASIVE APPROACH TO DIAGNOSIS OF UPPER GASTROINTESTINAL DISEASES. Area Qualita S.r.l., Milan, Italy 2015.Type: otherGastroPanel
2017Ebule, Ivo Alonge GastroPanel for the Diagnosis of Gastritis. A tool for Health Emergence. Nyaa Publishers, Yaounde, Cameroon, First Edition 2016. ISBN: 978-9956-454-52-4. Type: otherGastrointestinal
2017Perez-Perez GI, Portal-Celhay C, Olivares A, Francois F, Bini EJ, Blaser MJ. Evaluation of Helicobacter pylori –Infection and Serum Levels of Pepsinogen I, Pepsinogen II, and PG-I/PG-II Ratio in Different Gastrointestinal Conditions. Presentation at the XXVIII PanAmerican Congress of Digestive Diseases, XV PanAmerican Congress of Type: abstractGastroPanel
2017Lynch K, Sellers T, Ennulat D, Schwartz. Evaluation and use of a human ELISa method for measuring pepsinogen I in monkey serum. Presentation at the AACC annual meeting 2004 in Los Angeles, Ca, USA, July 25-29, 2004. A quick test for perendoscopic diagnosis of hypolactasia from postbulbar duodenaType: abstractPepsinogen I
2017Koskinen SEconomic Evaluation of GastroPanel in Early Detection of Gastric Diseases/GastroPanel-testin käyttö mahalaukun sairauksien varhaisdiagnostiikassa – taloudellinen evaluaatio. Helsinki University of Technology, Dept. Engineering Physics and mathomatics, labType: otherGastroPanel
2017Hajsheykholeslami A, Rakhshani N, Shahidi SM, Rafiee R, Azimi K, Mohammadi N, Fakhar R, Babaei M, Tabib SM, Saliminejhad M, Nobakht H, Nasiri J, Dooghaie Moghadam M, Saeidi S, Didehvar R, Zendehdel N, Massarrat SCOURSE OF PANGASTRITIS AND SERUM MARKERS PEPSINOGEN I (PEPI) ,PEPSINOGEN II(PEPII) AND GASTRIN17 (G17) IN FIRST-DEGREE RELATIVES OF GASTRIC CANCER PATIENTS, 2 YEARS AFTER H.PYLORI ERADICATION IN A DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED STUDY. Gut 2007Type: abstractGastroPanel
2017Di Mario F, Farkas HP, Ferrara F, Dal Bo N, Slongo T, Marcello R, Liatopoulou S, Gnocchi A, Corrente V, Bertele A, Rugge M, Scarpignato C. Are All Patients With Histological Diagnosis of Atrophic Gastritis Really At Risk of Developing Gastric Cancer? Assessment of Gastric Acid Production by Correlation Between Maximal Acid Output and Pepsinogen I. Gastroenterology 2014; 146 (5): S-314–315. DType: abstractGastroPanel
2017Moore AR, Steele I, Murugesan SV, Tiszlavicz L, Dockray GJ, Varro Andrea, Pritchard DM. A Combination of Fasting Serum Gastrin Concentration, Pepsinogen 1/2 Ratio and Helicobacter pylori IgG Antibody Serotype Accurately Predicts Gastric Mucosal Preneoplasia in a Large European Cohort. Lecture presentation at DDW 2015: 242. Gastroenterol 2015Type: otherGastroPanel
2017Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F.Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther 2017;1-11, doi: 10.1111/apt.1424Type: scientific articleGastroPanel
2000Suovaniemi OAggressive Innovation and Patenting StrategyType: articleCompany
2008PhD student: Tran Khanh HOAN, Supervisors: Prof. Phung Dac Cam, Prof. Le Huy ChinhStudy on Helicobacter pylori antibody pepsinogen, gastrin-17 concentrations and their relationship w with chronic gastritis. Ph.D. Thesis. L’Hôpital Francais De Hanoi, Vietnam. 17.9.2008.Type: otherGastroPanel
2010Mikko SalaspuroAsetaldehydi-maailman yleisin karsinogeeni, Erikoislääkäri 1/2010 . Erikoislääkäri 2010; 20 (1): 36-34Type: articleAsetaldehydi
2010HLKapselilla vatsasyöpää vastaan, Hoivapalvelut 1.2.2010Type: articleAsetaldehydi
2010Markku NiiniluotoOsmo Suovaniemi- Kantapään kautta pörssikomeetaksi, MeidänSuomi Kevät 2010Type: articleCompany
2009Maisa JärveläPieni pisara riittää, Kokkola 3009 30.9.2009; 40Type: articleGastric disease
2008Suovaniemi O GastroPanel- ja GastroView- tutkimukset dyspepsian turvallisen ja kustannustehokkaan hoidon kehittämType: articleGastric disease
2009Perttula M.Tähystyksen voi välttää. Kauneus&Terveys 2009; 7Type: articleGastric disease
2009AK.Vatsavaivojen syyt kannattaa selvittää. Uusi Torniolainen Kaupunkilehti 26.3.2009;11.Type: articleGastric disease
2009Tuhkanen M-L.Paksusuolensyöpää kannattaa seuloa aktiivisesti. Lääkärisanomat 2009; 2:24-25Type: articleGastric disease
2009Kysteiinikapseli torjuu syöpää. Kemia-Kemi 2009; 36(2):21Type: articleAsetaldehydi
2009Järvinen T. Vatsavaivojen syyt kannattaa selvittää ajoissa.Ykköset 29.1.2009; 5:9Type: articleGastroPanel
2008Di Mario FGastroPanel:"biopsia sierologica".Media Planet.Gastroenterologica.Sept 2009:4Type: articleGastroPanel
2008Suovaniemi OGastroView ja GastroPanel- dyspepsian primaaritutkimuksia. Yksityislääkäri 2008; 5:93-98Type: articleGastroPanel
2008Silasvuo MBiohit Oyj vie suomalaista huippuosaamista maailmalle. Yksityislääkäri 1/2008 sivut 99-101Type: articleCompany
2009Di Mario F, Gatta L, Franzè A, Scarpignato C, Dal Bò N, Guida L.Eradication rate of helicobacter pylori in immigrant patients compared to Italian patients: Results of a clinical trial. Gut 2009; 58 (Suppl II):A255.Type: abstractGastroPanel
2008Franzè J, Parodi A, Savarino E, Morana E, Bertelè A, Savarino V, Di Mario F.A comparison between lactose breath test and quick test on duodenal biopsies for lactase deficiency, in patients with self reported lactose intolerance. Gut 2009; 58(Suppl II):A261.Type: abstractGastroPanel
2008Kanizaj TF, Katiciv M, Colic Cvrlje V, Skurla B, Prskalo M, Mrzljak A, Naumovski Mihailic S.Correlation of serological markers with atrophic gastritis and intestinal metaplasia histopathologic finding before and after Helicobacter pylori eradication therapy. Gut 2009; 58 (Suppl II):A109.Type: abstractGastroPanel
2009Kim N, Eshmuratov A, Nah JC The correlation of Endoscopic and Histological Diagnosis of Gastric Atrophy. DDW 2009; T1074 Gastroenterol 2009; 136(5): A-732 (W1820)Type: abstractGastroPanel
2009Linderborg K, Marvola T, Marvola M, Salaspuro M, Färkkilä M, Väkeväinen SEliminating carcinogenic acetaldehyde from achlorhydric stomach with cysteine. Gut 2009; 58 (Suppl I (Suppl II):A61.Type: abstractAcetaldehyde
2009Melnikova E, Maev I, Kashin S, Nadezhin A, Kryokova T, Shubin L.Usefullness of non-invasive detection of H.pylori- associated gastric precancerous conditions and early gastric cancer (EGC). Gut 2009; 58 (Suppl II): A109.Type: abstractGastroPanel
2009Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Persson C, Shakeri R, Abnet CC, Kamangar F, ISlami F, Dawsey SM, Boffetta P, Engstrand L, Malekzadeh R, Ye W. Effect of clinical use of proton pump inhibitors on serum level of gastrin-17, pepsinogen I, and pepsinogen II. Gut 2009; 58 (Suppl II): A273.Type: abstractGastroPanel
2009Purveeva KV, Konkov M, Sclanckaya, Lapina T, Ivashkin V.The histological dynamics and serum levels of pepsinogen I, II and gastrin-17 in atrophic gastritis after Helicobacter pylori’s eradication. Gut 2009; 58 (Suppl II):A257.Type: abstractGastroPanel
2010Jonna Heiniluoma. Ideapark Liikekaupungin uutiset 2007; 40:11Vaivaako vatsa?Huolettaako närästys?Type: articleGastric disease
2010Suovaniemi OThe Gastro Panel examination in the treatment of dyspepsia, Yksityislääkäri 2007:4,pages 104-106Type: articleGastroPanel
2007Suovaniemi OGastroPanel-tutkimus osaksi dyspepsian hoitokäytäntöä, Yksityislääkäri 2007:4, sivut 104-106Type: articleGastroPanel
2007Triballi V.Suomalainen GastroView- tutkimus vatsaoireiden syiden selvittäjä. Ykköset 23.8.2007; 34:28Type: articleGastroPanel
2009Ghamgro I, Basu S, Vidyarthi M, McTaggert C, Hollanders D.The Incidence of Lactose Deficiency in an endoscopically and historically normal group of white Caucasians.Gastroenterology today 2009; 19(3):76-78Type: scientific articleLactose Intolerance
2007van Marrewijk CJ, van Oijen MGH, Laheij RJF, Paloheimo LI, Mujakovic S, Fransen GAJ, Numans ME, de Wit NJ, Muris JWM, Grobbee DE, Knottnerus AJ, Jansen JBM.THE INFLUENCE OF GASTRIC STATUS ON EMPIRICAL DYSPEPSIA TREATMENT SUCCESS. Gut 2007; 56(Suppl III); A196.Type: scientific articleGastroPanel
2007Backlanova OADiagnosis of precancer lesions of stomach in group of patients selected by non noninvasive Coloproctology 2007; 5:A57.Type: scientific articleGastroPanel
2005Pyurveyeva KV, Lapina TL, Ivashkin VT, Kon'kov MYu, Sklyanskaya OA, Serova AG, Vasil'yeva NYu.Serum pepsinogen I, pepsinogen II and gastrin-17 in diagnostics of atrophic gastritis. RZGGK 2005; 3:48-51.Type: scientific articleGastroPanel
2005Sipponen PNobel kliiniselle havainnolle, joka mullisti hoitokäytäntöjä. Yksityislääkäri 2005; 6:5Type: scientific articleGastric disease
2005Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen MLow circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol 2005 October;11(38):5988-5992Type: scientific articleGastroPanel
2004Kalach N, Legoedec J, Wann A-R, Bergeret M, Dupont C, Raymond JSerum Levels of Pepsinogen I, PepsinogenII, and Gastrin-17 in the Course of Helicobacter pylori Gastritis in Pediatrics Journal of Pediatric Gastroenterology and Nutrition39:568–570 November 2004Type: scientific articleGastroPanel
2006Suovaniemi OGastroPanel dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen Erillispainos Yksityislääkäri-lehti 5/06Type: articleGastroPanel
2007Suovaniemi OBiohitin GastroPanel-keksintö Kiinan terveydenhuollon käyttöön. Yksityislääkäri 2007: 1:95-99Type: scientific articleGastroPanel
2006Cao Q, Ran Z, Xiao SScreening of Atrophic Gastritis and Gastric Cancer Using Serum Pepsinogen, Gastrin-17 and Helicobacter pylori IgG Antibodies. Chin J Gastroenterol 2006;11 (7): 388-394. (In Chinese).Type: scientific articleGastric disease
2006Hoan TK, Paloheimo L, Cam PD, Hop TVEvaluation of serum pepsinogen and gastrin-17 levels on patients with chronic atrophic gastritis. Tap Chí Khoa Học Tiệu Hóa Việt Nam 2006; 1(3):13-21.Type: scientific articleGastroPanel
2006Hopkin MChew on this: the gum that fights cancer. Published online www.nature.com, 22 May 2006.Type: scientific articleAcetaldehyde
2005Järvinen LTapauselostus: GastroPanel - uusi ase dyspepsian turvallisen hoidon kehittämiseen. Yksityislääkäri 2005; 2: 94-98. Also available in English: A new tool for developing a safe treatment for dyspepsia.Type: scientific articleGastrin-17
2005Loikkanen S.Lääketieteen Nobel helikobakteeritutkimuksesta. Mahahaava on pian historiaa. KemiaKemi 2005; 8(32): 32-33.Type: scientific articleGastric disease
2005Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN.Non-invasive Diagnosis of Gastric Mucosal Precancerous Changes. 6th International Gastric Cancer Congress IGCC, Yokohama, Japan, 2005 May 4-7. Medimond S.r.l. F504C0631: 329-332.Type: scientific articleGastric disease
2005Suovaniemi ODiagnostics to improve evidence-based medicine (EBM). ECL 2005; 24(2):12-13.Type: scientific articleGastroPanel
2005Suovaniemi O.GastroPanel - An opportunity to develop the treatment praxis of dyspepsia. ECL 2005; 24(4): 10-11.Type: scientific articleGastroPanel
2005Suovaniemi OKeksijänä Suomessa. Terveystieto 2005; 4: 4-8. Also available in English: Being an inventor in Finland.Type: scientific articleCompany
2004Sipponen P, Laxén F, Huotari K, Härkönen MAtrofiseen gastriittiin liittyvä matala seerumin B12-vitamiinitaso - Vanhenevien miesten terveysriski? Suomen Lääkärilehti 2004; 59/5: 379-384.Type: scientific articleGastroPanel
2004Suovaniemi OGastroPanel in the Screening, Diagnosis and Prevention of Diseases. Hospital Post 4/2004; July-August: 11.Type: scientific articleGastroPanel
2004Suovaniemi OGastroPanelin käyttö seulontatutkimuksissa. Yksityislääkäri 2004; 3:97-98.Type: scientific articleGastroPanel
2004Suovaniemi OPrueba nueva ofrece avaces en el tamisaje y diagnóstico gástrico. LabMedica en Español 2004; July-August: 21-24.Type: scientific articleGastroPanel
2003Baqir HI, Al-Aubaidi MH, Fakhri S, Al-Mousili MM, Hamadi SAEvaluation of serological tests for the diagnosis of Helicobacter pylori infection. IJGE 2003; 4(1): 41-47.Type: scientific articleGastroPanel
2003Heiniö JAggressiivinen innovointi- ja patentointistrategia tie menestykseen, Nesteannostelija- ja instrumenttikeksintöjä, Yksityislääkäri 2003; 1: 96-98.Type: scientific articlePatents
2003Hentola H.Biohit - kansainvälinen bioteknologiayritys, Yksityislääkäri 2003; 3: 104-106.Type: scientific articleGastric disease
2003Hurme J. Laboratoriotutkimus atrofisen gastriitin toteamisessa. Yksityislääkäri 2003; 4: 98Type: scientific articleGastroPanel
2003Laxen F, Sipponen P, Tilvis RAtrofinen gastriitti – sairaus, joka jää usein vähälle huomiolle. Kliin Lab 2003: 4; 78-81, Yksityislääkäri 2003; 2: 96-98.Type: scientific articleGastroPanel
2003Lehtinen PTesti seuloo terveet ja sairaat mahat. Mediauutiset: 30.5.2003.Type: scientific articleGastroPanel
2003Suovaniemi ODetermination of H. pylori-related disease. Innovations in Pharmaceutical Technology, September 2003.Type: scientific articleGastric disease
2003Suovaniemi OHelikobakteeri-infektion ja atrofisen gastriitin sekä siihen liittyvien tautiriskien toteaminen verinäytteestä. Itä-Suomen Lääketiede 23.-25.9.2003, TerveysTieto: 2003; 4: 18-19.Type: scientific articleGastroPanel
2003Suovaniemi O, Härkönen M, Paloheimo L, Sipponen P. GastroPanelDiagnosing Atrophic Gastritis From Serum - Providing a Tool for Evidence-based Medicine. Business Briefing: Global Health Care, 2003, 1-4.Type: scientific articleGastroPanel
2003Suovaniemi O, Paloheimo L, Härkönen M, Sipponen PAtrophic gastritis - a Disease with Significant Clinical Impact. Clinical Note. ECL 2003; 22 (2): 16-19.Type: scientific articleGastroPanel
2003Wandzel P, Hartleb M, Waluga M, Matyszczyk B, Boldys H, Romanczyk TNon-Invasive Diagnosis of Multifocal Atrophic Gastritis. Diagn Lab 2003; 39: 63-72. (In Polish).Type: scientific articleGastric disease
2002Sipponen P, Forsblom E, Suovaniemi O, Härkönen MApplication of ELISA assays of pepsinogen I, gastrin-17 and H. pylori antibodies for non-endoscopic diagnosis of atrophic gastritis. Russian J Gastroenterology, Haepatology, Coloproctology 2002; Vol.XII, No.3: 46-51.Type: scientific articleGastroPanel
2002Suovaniemi OAtrofisen gastriitin toteaminen verinäytteestä. Yksityislääkäri 2002; 5:77-78.Type: scientific articleGastroPanel
2002Suovaniemi OBiohit innovaatioiden sampo. Yksityislääkäri 2002;4:62-63.Type: scientific articleGastric disease
2002Suovaniemi OHelikobakteeri-infektion ja atrofisen gastriitin paljastava testipaneeli. Yksityislääkäri 2002;3: 76-79.Type: scientific articleGastroPanel
2002Suovaniemi ODetermination of H. pylori -related disease. Innovations in Pharmaceutical Technology 2002; Vol 02 (10): 65-68.Type: scientific articleGastroPanel
2002Suovaniemi OTest Panel for the Determination of Helicobacter pylori -Infection and Atrophic Gastritis. UEMS, Compendium 2002;28-31.Type: scientific articleGastroPanel
2002Suovaniemi O, Härkönen, M, Paloheimo LI, Sipponen PDiagnosis of Atrophic Gastritis from a Serum Sample. Jordan Medical Journal 2002; 2 (Vol 36): 117-121.Type: scientific articleGastroPanel
2001Sipponen P, Härkönen M, Alanko A.Atrofisen gastriitin toteaminen verinäytteestä. Suomen Lääkärilehti 2001;38:3833-3839.Type: scientific articleGastroPanel
2009McNicholl AG, Forne M, Barrio J, de la Coba C, Gonzalez B, Rivera R, Esteve M, Fernandez-Bañares F, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras C, Esteban C, Santolaria S, Gomollon F, Valle J, Gisbert JBOn behalf of the H. pylori Study Group of the Asociación Española Gastroenterología (AEG). Accuracy of GastroPanel for non invasive diagnosis of atrophic gastritis. Helicobacter 2009;14(4):315-316 (W1.5)Type: abstractGastroPanel
2010Mikko SalaspuroFunctionality and effects of the Acetium™ capsuleType: otherAcetium
2010Mikko Salaspuro, Tuuli MarvolaAcetaldehyde is a common but poorly known carcinogenic substanceType: otherAcetaldehyde
2010Mikko Salaspuro, Tuuli MarvolaFood products may contain plenty of acetaldehyde - Concentrations are trade secretsType: otherAcetaldehyde
2010Mikko Salaspuro, Tuuli MarvolaAcetaldehyde risk factors are based on strong scientific evidenceType: otherAcetaldehyde
2010Mikko Salaspuro, Tuuli MarvolaFinnish scientists as pioneers in acetaldehyde researchType: otherAcetaldehyde
2008Leja M, Kupcinskas L, Lin J-T, Funka K, Janciauskas D, Sudraba A, Jonaitis L, Ivanauskas A, Chiu H-MThe Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology. Gastroenterology 2008; 134(4 suppl11): A478.Type: abstractGastroPanel
2008Nouvenne A, Maini A, Cavallaro LG, Merli R, Guida L, Morana E, Curlo M, Iori A, Martelli L, Martelli M, Cavestro GM, Pelosini I, Scarpignato C, Franzè A, Di Mario FCurcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic of an Agonist of Vanilloid Receptor? Gastroenterology 2008; 134(4 suppl11): A629.Type: abstractGastric disease
2008Sipponen P, Härkönen M, Salaspuro MNäkökulma: Atrofinen gastriitti jää usein liian vähälle huomiolle. Suomen Lääkärilehti 2008; 15 (63):1428-1430aType: scientific articleGastroPanel
2008Stankevich LIThe experience of using GastroPanel (BIOHIT) in diagnosis and control of the treatment of HP-associated gastritis. Laboratory Medicine 2008; 9: 53-57.Type: scientific articleGastroPanel
2008Cavallaro L, Minelli R, Iori A, Merli R, Nouvenne A, Maini A. Bertelè A, Franzè A, Di Mario FUsefulness of “serological gastric biopsy” in patients affected by autoimmune thyroid disease (AITD). Gut 2007; 56(Suppl III):A237.Type: abstractGastric disease
2006Cavallaro LG, Maini A, Nouvenne A, Merli R, Iori V, Cavestro GM, Rugge M, Franzè A, Di Mario FSerum Pepsinogen II as a marker of aspirin related gastritis. Gut 2006; Vol 55 (suppl V): A283.Type: abstractPepsinogen II
2006Cavallaro LG, Merli R, Morana E, Iori V, Bertelè A, Cavestro GM, Colla G, Nervi G, Gnocchi A, Franzè A, Di Mario FGastroPanel® for detection of atrophic gastritis: The “Parma Model". Gut 2006; Vol 55 (suppl V): A285.Type: abstractGastroPanel
2006Guariso G, Basso D, Fasolo M, Conte S, Tasinato A, Navaglia F, Fogar P, Zambon CF, Grego E, Schiavon S, Plebani M. GastroPanelA Useful Screening Test in Pediatric Populations. Helicobacter 2006;11(4): 374 (09.07). Type: abstractGastric disease
2006Haj-Sheykholeslami A, Amirzargar A, Saeidi S, Rakhshani N, Nikbin B, Khosravi F, Ansaripour B, Moradi B, Massarrat SPepsinogen I and II and Gastrin 17 as Markers of different types and rades of gastritis. Gut 2006; Vol 55 (suppl V): A86.Type: abstractGastroPanel
2006Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L. Meurman JH, Salaspuro MAcetaldehyde production from ethanol by oral Viridans Streptococci. Presentation at the 11th International Congress on Oral Cancer (ICOOC) May 14-17 2006 in Grado, Italy. Type: abstractGastric disease
2006Linderborg K, Salaspuro M.Effect of acetaldehyde concentration in alcoholic beverages on salivary acetaldehyde. Presentation at the 11th International Congress on Oral Cancer (ICOOC) May 14-17 2006 in Grado, Italy.Type: abstractAcetaldehyde
2006Orlandi M, Netzer P, Inauen WIdentifying Lactose Intolerance with a novel biopsy-based rapid lactase test. Gut 2006; Vol 55 (suppl V): A98.Type: abstractLactose Intolerance
2006Salaspuro V, Kaihovaara P , Salaspuro MEliminating carcinogenic acetaldehyde from mild alcohol and dietary products with cysteine supplement. Presentation at the 11th International Congress on Oral cancer (ICOOC) May 14-17 2006 in Grado, Italy.Type: abstractAcetaldehyde
2006Valle J, López-Pardo R, Rodriguez-Merlo R, Pérez-Grueso M, Artaza T, Alcántara M, García-Vela A, Carrobles JValidity of a combination of Pepsinogen I and II, 17-Gastrin and Helicobacter Pylori antibodies (GASTROPANEL) for the serologic diagnosis of gastric atrophy. Gut 2006; Vol 55 (suppl V): A92.Type: abstractGastroPanel
2005Cavallaro LG, Bertolini S, Bosi S, Stefani N, Merli R, Liatopoulou S, Maini A, Maino M, Iori V, Cavestro G, Nervi G, Franze' A, Di Mario FGastrin-17 (G­17) and Serum Pepsinogen (SPGI) for Evaluation of Patients with Gastroesophageal Reflux Disease (GERD) Compared to Dyspeptics or Ulcerous.Gut 2005; 54 (Suppl VII):A105.Type: abstractGastric disease
2008Sipponen P., Salaspuro M., Härkönen M.Atrofinen gastriitti. Biomerkkiainetutkimus ja atrofinengastriitti – tärkeä mahalaukun syövän ja B12 vitamiinipuutoksen riskitila.Yksityislääkäri 3/2008 sivut 99-106Type: articleGastroPanel
2007Di Mario F, Franzè A, Gavallaro LCApproccio non invasivo alla malattia da reflusso gastroesofageo: Il GastroPanel. Update 2007; 1: InsertoType: articleGastroPanel
2007Telaranta-Keerie A, Härkönen MYlävatsavaivoja. Uusi Fuengirola 2007; 13:9Type: articleGastric disease
2007Suovaniemi OBiohitin GastroPanel-keksintö Kiinan terveydenhuollon käyttöön. Yksityislääkäri 2007; 1.Type: articleGastroPanel
2006Saarikko MOsmo Suovaniemen patentointivauhti huimaa päätä,Type: articleCompany
2006Saarikko MBioalan erikoistapahtuma Biotec 2006: Seminaareja kiiteltiin, mutta näyttely hiljenee. Kemia-Kemi 2006; 7: 31.Type: articleCompany
2006Siilasvuo M.Biohit kasvoi nyrkkipajasta pörssiyhtiöksi. Yksityislääkäri 2006; 4: 94-96.Type: articleCompany
2006Suovaniemi OGastroPanel dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen, Erillispainos Yksityislääkäri 2006; 5. (In English)Type: articleGastroPanel
2006Suovaniemi OGastroPanel dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen. TerveysTieto no 4/2006; 6-11.Type: articleGastroPanel
2005Suovaniemi O.Ainutlaatuinen tutkimus vatsavaivojen tautiriskien selvittämiseen. KunnallisSuomi, Marraskuu, 1/2 2005.Type: articleGastroPanel
2005Suomalaiskeksintö helpottaa helikobakteerin aiheuttamien sairauksien tutkimista. Lehdistötiedote, 17.10.2005.Type: otherGastroPanel
2005GastroPanel - innovative testing for gastric illnesses. Finland Focus 2005;15.Type: otherGastroPanel
2005Vatsavaivojen tutkiminen helpottuu. GE Healthcare. Mission Possible 2005: 4.Type: otherGastroPanel
2005Junttila HDyspepsiaan kiinni ilman gastroskopiaa. Mediauutiset. 29.4.2005. Nro 14:18.Type: articleGastroPanel
2005Juva LauriOnko Sinulla usein ylävatsavatsakipuja, oletko yli 50-vuotias? Onko mahaasi koskaan tutkittu? Demari 31.10.2005.Type: articleGastric disease
2005Lehtomaa K.Mahalaukun tähystyksistä pyritään karsimaan kolmasosa. KAKS ottaa koekäyttöön uuden GastroPanel –tutkimuksen. Kainuun Sanomat. Perjantaina 25. maaliskuuta 2005: A6.Type: articleGastroPanel
2005Pakkala Erpo.Helikobakteeri löytyy verikokeella. Mediuutiset Nro. 29, 21.10.2005:22.Type: articleGastroPanel
2005Sipponen P, Jauhonen P, Suovaniemi OGastroPanel dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen. Yksityislääkäri 2005; 6: 95-98.Type: articleGastroPanel
2005Suovaniemi OGastroPanel-tutkimus dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen. TerveysTieto 2005; 5: 18-20.Type: scientific articleGastroPanel
2005Suovaniemi OGastroPanelin käyttö tautien ennaltaehkäisyssä, diagnostiikassa ja seulontatutkimuksissa. TerveysTieto 2005; 1: 36-39.Type: scientific articleGastroPanel
2005Suovaniemi O. GastroPanel dyspepsian ja helikobakteeri-infektion turvallisen hoitokäytännön kehittämiseen. Yksityislääkäri 2005; 5: 96-98. Type: articleGastroPanel
2005Suovaniemi OKeksijänä Suomessa. Terveystieto 2005; 4: 4-8.Type: articleCompany
2005Suovaniemi O, Järvinen L, Sipponen PGastroPanel-diagnostiikkaa ja seulontaa. Yksityislääkäri 2005; 1:95-98.Type: articleGastroPanel
2004Annala M.Keksintö helpottaa vatsan tutkimusta. Helsingin Sanomat, 16.8.2004:D2. (In English) (In Swedish) (In Spanish)Type: articleGastroPanel
2004Hämäläinen S.Ylävatsavaivojen tautiriskit ajoissa selville, GastroPanel-tutkimus edistää ennaltaehkäisevää lääketiedettä. Yksityislääkäri 2004; 1: 97-98.Type: articleGastroPanel
2004Jauhonen PGastroskopia vai Gastropaneeli? Yksityislääkäri 2004; 4: 96-98.Type: articleGastroPanel
2004Lindgren A.Non-Invasive Stomach Mucosa Tests Are Now a Reality. Scandinavian Life Science Magazine 2004; 3: 37-38.Type: articleGastroPanel
2004Nousiainen JSalakavala helikobakteeri. Kunto & Terveys 2004; 2: 58-60.Type: articleHelicobacter
2004Peetsalu AUus väheinvasiivne maopaneelmeetod maohaiguste diagnoosimiseks ja prognoosimiseks. Moodne Meditsiin Apr 2004: 28-30.Type: articleGastroPanel
2004Rattazzi S.Un nuevo esame per il mal di stomaco. Donna Moderna 25.8.2004: 163.Type: articleGastroPanel
2007Minushkin OV, Zverkov IV, Topchii TB, Volodin PV, Shuleshova AGChronic autoimmune gastritis: diagnosis and features of the disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A101.troenterology, Hepatology, Coloproctology 2007; 5:A95.Type: abstractGastroPanel
2007Kurilovich SA, Reshetnikov OV, Krotov SA, Krotova VA, Bessonov PP, Vasielev RRAtrophic gastritis in two Siberian populations: serological screening. Russian Journal of Gastroenterology,Hepatology, Coloproctology 2007; 5:A95Type: scientific articleGastroPanel
2007Ilchishina TAInfluence of HP-infection diagnostic choice on evaluation of efficiency of eradication therapy. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A79.Type: abstractGastric disease
2007Ivanova LM, Kudinov NA, Nabatchikov GB, Lozovator AL, Razlivaeva NI, Terenkov VK.GastroPanel - clinical and morphological comparision. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A78.Type: scientific articleGastroPanel
2007Backlanova OADiagnosis of precancer lesions of stomach in group of patients selected by non-invasive screening of atrophic gastritis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A57.Type: abstractGastroPanel
2007Backlanova OAOpportunities of non-invasive screening of atrophic gastritis as precancer lesion of stomach. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A56.Type: abstractGastroPanel
2007Akimanko EI, Lubanskaya TG, Prohozheva AU, Omelchenko OVDiagnosis of gastrobiopsy and serological methods in diagnosis of gastric mucous pathology. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A50.Type: abstractGastroPanel
2007Drygina LB, Bigeldina NA”GastroPanel” test in stomach diseases diagnostics. Clinico-Laboratory Consilium 2007; 18:55-65. Type: scientific articleGastroPanel
2007Rethetnikov OV, Kurilovich SA, Krotov SA, Krotova VANoninvasive diagnosis of atrophic gastritis by serology. Clinical Laboratory Diagnostics 2007; 11:39-41.Type: scientific articleGastric disease
2010Reijo IkävalkoOnko sinulla hapoton maha? Viva 08-2010Type: articleGastroPanel
2010BiohitMonoclonal Antibodies brochureType: brochureProducts
2012BiohitHelicobacter pylori quick test brochureType: brochureProducts
2010Päivi RepoAlkoholissa ja tupakassa samaa syöpää aiheuttavaa ainetta HS 11-2009Type: articleAcetaldehyde
2010European Supply Chain ManagementHealthy Innovations ESCM 06-2009Type: articleProducts
2010Markku SummaInnovations for Health, Business Finland 2-2008Type: articleCompany
2010Mikko MarttinenLasten ruoissa piilee syöpäriski, IS 2-2010Type: articleAcetaldehyde
2010Heli VäyrynenMyrkkyä vai ei, Viikko Kaleva 7-2010Type: articleAcetaldehyde
2010Markku NiiniluotoOlen Suomalainen, Meidän Suomi 2010Type: articleCompany
2010Tarja HallaOmenalta tuoksuva aromi joutuu suurennuslasin alle, Maaseudun tulevaisuus 11-2009Type: articleAcetaldehyde
2010Biohit Biohit – Innovating for Health, Corporate profile brochureType: brochurecompany